0001493152-17-005734.txt : 20170522 0001493152-17-005734.hdr.sgml : 20170522 20170522153356 ACCESSION NUMBER: 0001493152-17-005734 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20170331 FILED AS OF DATE: 20170522 DATE AS OF CHANGE: 20170522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRASCIENCE INC CENTRAL INDEX KEY: 0000727672 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 411448837 STATE OF INCORPORATION: MN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-13092 FILM NUMBER: 17860793 BUSINESS ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 847-0200 MAIL ADDRESS: STREET 1: 11568 SORRENTO VALLEY ROAD STREET 2: SUITE 11 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC /MN DATE OF NAME CHANGE: 19931119 FORMER COMPANY: FORMER CONFORMED NAME: GV MEDICAL INC DATE OF NAME CHANGE: 19920703 10-Q 1 form10-q.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2017

Commission file number 0-13092

SPECTRASCIENCE, INC.

(Exact name of registrant

as specified in its charter)

Minnesota		41-1448837
(State or other jurisdiction		(I.R.S. Employer
of incorporation or organization)		Identification Number)

11568 Sorrento Valley Rd., Suite 11

San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 847-0200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES [X] NO [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit and post such files). YES [X] NO [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]	Accelerated filer [ ]

Non-accelerated filer [ ]	Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

YES [ ] NO [X]

The number of shares of the registrant’s common stock, par value $0.01 per share, outstanding on May 12, 2017 was 1,440,320,059.

SPECTRASCIENCE, INC.

FORM 10-Q

For the Three Months Ended March 31, 2017

TABLE OF CONTENTS

		Page
PART I	FINANCIAL INFORMATION:

Item 1.	Financial Statements (Unaudited)	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	25

Item 4.	Controls and Procedures	25

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	26

Item 1A.	Risk Factors	26

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26

Item 3.	Defaults Upon Senior Securities	27

Item 4.	Mine Safety Disclosures	27

Item 5.	Other Information	27

Item 6.	Exhibits	27

SIGNATURES		28

PART I FINANCIAL INFORMATION:

Item 1. Financial Statements

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

	March 31, 2017			December 31, 2016
	(Unaudited)
ASSETS
Current assets:
Cash	$	100,001		$	3,550
Accounts receivable, net		-			950
Inventory		97,423			90,594
Prepaid expenses and other current assets		225,621			266,749
Total current assets		423,045			361,843

Patents, net		984,687			1,024,524
	$	1,407,732		$	1,386,367

LIABILITIES AND SHAREHOLDERS' DEFICIT
Current liabilities:
Accounts payable	$	1,499,584		$	1,318,737
Accrued expenses		2,458,162			2,278,042
Notes payable- related parties		35,000			35,000
Note payable		112,982			137,982
Convertible debt, net of discounts of $325,848 as of March 31, 2017 and $203,444 as of December 31, 2016		6,131,274			6,211,861
Derivative liability		833,082			819,928
Total current liabilities		11,070,084			10,801,550

Long-term secured convertible debt		1,350,000			1,100,000

COMMITMENTS AND CONTINGENCIES

Mezzanine equity
Series B Convertible Preferred Stock, $.01 par value; 2,585,000 shares authorized, issued and outstanding as of March 31, 2017 and December 31, 2016; liquidation value of $517,000 plus accumulated and unpaid dividends of $106,931 as of March 31, 2017 and December 31, 2016		25,850			25,850
Series C Convertible Preferred Stock, $.01 par value; 500,000 shares authorized, issued and outstanding as of March 31, 2017 and December 31, 2016; liquidation value of $100,000 as of March 31, 2017 and December 31, 2016		5,000			5,000
Total mezzanine equity		30,850			30,850

Shareholders' deficit
Series A Convertible Preferred Stock, $.01 par value; 0 shares authorized, issued and outstanding as of March 31, 2017 and December 31, 2016		-			-
Series AA Super Voting Preferred Stock, $.001 par value; 3,000 and 0 shares authorized, issued and outstanding as of March 31, 2017 and December 31, 2016		3			3
Common stock, $.01 par value; 1,996,000,000 shares authorized; 1,413,320,059 and 883,671,222 shares issued and outstanding as of March 31, 2017 and December 31, 2016		14,133,200			8,836,712
Additional paid in capital		29,792,890			34,582,771
Accumulated deficit		(54,969,295	)		(53,965,519	)
Total shareholders' deficit		(11,043,202	)		(10,546,033	)
	$	1,407,732		$	1,386,367

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Operation

(Unaudited)

	Three Months Ended
	March 31,
	2017			2016

Operating expenses:
Research and development	$	130,842		$	194,007
General and administrative		279,732			307,841
Sales and marketing		74,854			79,413
		485,428			581,261

Loss from operations		(485,428	)		(581,261	)

Other income (expense)
Interest expense		(184,709	)		(374,130	)
Change in fair value of derivative and warrant liabilities		167,787			(887,494	)
Amortization of derivative and warrant liabilities discount		(130,408	)		(141,561	)
Amortization of deferred debt issuance costs and original issue discount		(6,734	)		(62,530	)
Loss on issuance of variable rate debt		(368,743	)		-
Gain on extinguishment of debt		10,551			1,166
Loss on foreign exchange transactions		(6,092	)		(8,924	)
Other income (expense), net		-			(1,600	)
		(518,348	)		(1,475,073	)

Net loss	$	(1,003,776	)	$	(2,056,334	)

Basic and diluted loss per share	$	(0.00	)	$	(0.00	)

Weighted average common shares outstanding: Basic and diluted		1,090,120,075			609,825,530

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statement of Shareholders' Deficit

For the three months ended March 31, 2017

(unaudited)

	Series AA Super								Additional						Total
	Voting Preferred				Common Stock				Paid-In			Accumulated			Shareholders'
	Shares		Amount		Shares		Amount		Capital			Deficit			Deficit

Balance December 31, 2016		3,000	$	3		883,671,222	$	8,836,712	$	34,582,771		$	(53,965,519	)	$	(10,546,033	)

Non cash issuance of stock options		-		-		-		-		40,001			-			40,001
Conversion of convertible debt		-		-		529,648,837		5,296,488		(4,830,174	)		-			466,314
Non cash issuance of warrant for consulting services		-		-		-		-		292			-			292
Net loss		-		-		-		-		-			(1,003,776	)		(1,003,776	)

Balance March 31, 2017		3,000	$	3		1,413,320,059	$	14,133,200	$	29,792,890		$	(54,969,295	)	$	(11,043,202	)

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

	Three Months Ended March 31,
	2017			2016
Operating activities:
Net loss	$	(1,003,776	)	$	(2,056,334	)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization and depreciation		39,837			40,552
Non-cash interest from forbearance on and issuance of variable rate convertible debentures		385,102			94,329
Non-cash issuance of stock options and warrants		40,001			40,001
Non-cash (income) expense related to commitment of common stock in excess of authorized shares		(38,902	)		131,504
Amortization of derivative and warrant liabilities discount		130,408			141,561
Amortization of deferred debt issuance costs and original issue discount		6,734			62,530
Issuance of debt and common stock for services		11,000			350
Change in fair value of derivative and warrant liabilities		(167,787	)		887,494
Gain on extinguishment of debt		(10,551	)		(1,166	)
Changes in assets and liabilities:
Accounts receivable		950			7,061
Inventory		(6,829	)		(31,639	)
Prepaid expense and other assets		41,128			36,887
Accounts payable		180,844			127,720
Accrued expenses		199,961			112,154
Net cash used in operating activities		(191,880	)		(406,996	)

Investing activities:
Net cash used in investing activities		-			-

Financing activities:
Proceeds from issuance of convertible notes payable		309,000			300,000
Proceeds from issuance of notes payable to related parties		-			35,000
Payments on convertible notes payable		(669	)		-
Debt issuance costs		(20,000	)		(53,712	)
Net cash provided by financing activities		288,331			281,288

Net decrease in cash		96,451			(125,708	)

Cash, beginning of year		3,550			127,493

Cash, end of period	$	100,001		$	1,785

Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for:
Interest	$	1,000		$	-
Income taxes	$	-		$	-
Non Cash Investing and Financing Activities:
Conversion of convertible notes and accrued interest to common stock	$	88,419		$	75,812
Conversion of interest payable to increase in note	$	13,767		$	-
Conversion of note payable to convertible note payable	$	25,000		$	-

See accompanying summary of accounting polices and notes to unaudited condensed consolidated financial statements.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements

1. Nature of Business and Basis of Presentation

Description of Business

SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).

The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.

On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.

The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.

Basis of Presentation

The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the three month period ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

Going Concern

Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

As of March 31, 2017, the Company had a working capital deficit of $10,647,039 and cash of $100,001, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company uses agents to assist it with raising capital and has commenced raising capital on its own. During the three months ended March 31, 2017, the Company raised $289,000, net of transaction costs of $20,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of March 31, 2017, Convertible Debentures with a face value of $5,998,875 held by 80 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

2. Summary of Significant Accounting Policies

Revenue recognition

The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

Consolidation

The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

Risks and Uncertainties

The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

Use of Estimates

The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

Inventory Valuation

The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

Valuation of Long-lived Assets

The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

Variable Conversion Rate Debentures

Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

Over Commitment of Shares

Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.

Stock-Based Compensation

The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.

The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.

As of March 31, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At March 31, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 26,725,761 shares were exercisable. Awards under the Company’s EIP generally vest over four years.

The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the three month periods ended March 31, 2017 and 2016.

Earnings (Loss) Per Share

Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.

For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

	March 31, 2017		March 31, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		1,604,110,127		378,651,041
Options		34,168,800		34,168,800
Warrants		111,200,650		132,875,170
Total		1,752,564,577		548,780,011

The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:

	Three Months Ended
	March 31,
	2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,003,776	)	$	(2,056,334	)
Net loss for diluted earnings per share	$	(1,003,776	)	$	(2,056,334	)

Denominator:
Weighted average basic shares outstanding		1,090,120,075			609,825,530
Denominator for diluted earnings per share-Adjusted weighted average shares		1,090,120,075			609,825,530

Income (loss) per share
Basic	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)

Inventory

Inventory consisted of the following at March 31, 2017 and December 31, 2016:

	March 31, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.

Recently Adopted and Issued Accounting Pronouncements

In August 2014, the FASB issued FASB ASU2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. FASB ASU 2014-15 changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. These changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. These changes became effective for the Company for the 2016 annual period. Management has evaluated the impact of the adoption of these changes and has determined there will be no material impact on the consolidated financial statements. Subsequent to adoption, this guidance will need to be applied by management at the end of each annual period and interim period therein to determine what, if any, impact there will be on the consolidated financial statements in a given reporting period.

In April 2015, the FASB issued ASU No 2015-3, Simplifying the Presentation of Debt Issuance Costs. This update changes the presentation of debt issuance costs in the balance sheet. ASU 2015-03 requires debt issuance costs related to a recognized debt obligation to be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability rather than being presented as an asset. Amortization of debt issuance costs will continue to be reported as interest expense. In August 2015, the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements”. This ASU clarified guidance in ASC 2015-03 stating that the SEC staff would not object to a company presenting debt issuance costs related to a line-of-credit arrangement on the balance sheet as a deferred asset, regardless of whether there were any outstanding borrowings at period-end. This update is effective for annual and interim periods beginning after December 15, 2015, which required us to adopt these provisions in the first quarter of 2016. This update was applied on a retrospective basis, wherein the balance sheet of each period presented was adjusted to reflect the effects of applying the new guidance. The adoption of this guidance did not have a material impact on our consolidated financial statements.

In November 2015, the FASB issued ASU No 2015-17, Income Taxes (Topic 740). The amendments in ASU 2015-17 change the requirements for the classification of deferred taxes on the balance sheet. Currently, GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, the amendments in this ASU require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The pronouncement is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2016. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. The Company has early adopted this pronouncement for the fiscal reporting period ended December 31, 2016, and has reclassified the presentation of deferred income taxes in the prior period to conform with the current year classification in the consolidated balance sheets. As a result of the Company having recognized a valuation reserve for the entire deferred tax liability balance at March 31, 2017 and December 31, 2016, there is no impact of the presentation of deferred income taxes in our financial statements.

In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.

Reclassifications

Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

3. Liabilities

Note Payable

In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest accrues at 20% from October 1, 2015 until paid. During the three months ended March 31, 2017, $25,000 principal of this note was assigned to a third party who paid a like amount to the holder of the note. The balance of the note outstanding at March 31, 2017, $112,982, continues to accrue interest at 20%.

Notes Payable- Related Parties

During the three months ended March 31, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remains $35,000 at March 31, 2017.

Convertible Debentures

As of March 31, 2017, the Company has issued and outstanding fixed rate Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through March 31, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to March 31, 2013 do not contain such an exchange clause. During the three months ended March 31, 2017, Debentures with an accumulated principal balance of $150,000 and $13,767 of accrued interest were assigned to a third party note holder. The new notes contain variable conversion rates discussed below. The gross amount of Debentures with fixed conversion rates outstanding is $5,977,082 as of March 31, 2017.

During the three months ended March 31, 2017, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $480,040 as of March 31, 2017.

As of March 31, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:

	March 31, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		60,000			320,000
Issuance of debentures for services		10,000			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(82,345	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,457,122			6,415,305
Less unamortized costs of financing		325,848			203,444
Convertible debt, net of unamortized costs	$	6,131,274		$	6,211,861

Convertible debt in default	$	5,998,875		$	5,991,570

Secured Convertible Note

During the three months ended March 31, 2017, the Company issued for cash of $250,000 Secured Convertible Debentures (the “Secured Debentures”) to two accredited investors. The terms of the Debentures are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company. In addition, the Company issued to the holder of $100,000 Secured Debentures, a five year common stock purchase warrant to purchase up to 5,000,000 shares of common stock with an exercise price of $0.02 per share. The value of this warrant, $292, was determined using the Black Sholes Method and was reflected as a discount to the Secured Debenture.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

Derivative Liability

Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at

fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using the Black Scholes Model. The period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.

The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.

The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under the Company’s control. Therefore, the resulting effect on net loss is subject to significant fluctuation and will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.

In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock. For the three months ended March 31, 2017, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 1,166,000,000 shares.

As of March 31, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

							Commitment
							In Excess of
				Conversion			Authorized
	Warrants			Feature			Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352
Change in fair value at year end		(55,329	)		(112,458	)		-			(167,787	)
Elimination of liability on conversion		-			(410,509	)		-			(410,509	)
Over commitment of stock		-			-			(38,902	)		(38,902	)
Balance at March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

4. Shareholders’ Deficit

Common Stock

During the three months ended March 31, 2017, holders of Convertible Debentures with a face value of $82,345 and accrued interest of $6,074 converted their debentures into 529,648,837 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $15,651.

Warrants

During the three months ended March 31, 2017, in conjunction with the sale of Convertible Debentures, the Company issued a five-year common stock purchase warrant to acquire up to 5,000,000 shares to holders of the Debentures. In addition, the Company issued a five-year common stock purchase warrant to acquire up to 500,000 shares to an agent who assisted in this financing. These warrants have an exercise price of $0.02 per share. The value of the warrants was determined using the Black Sholes Model. The value of the warrant issued to the note holder, $2,925, was reflected as a discount to the note and the value of the warrant issued to the agent, $292, was reflected as a non-cash operating expense.

In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black Scholes Model and was included as non-cash expenses and additional paid-in capital during the three months ended March 31, 2016.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

The balance of all warrants outstanding as of March 31, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		5,500,000		$	0.0200	$	0.0006
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at March 31, 2017		111,200,650		$	0.0742

Exercisable at March 31, 2017		111,200,650		$	0.0742

Stock Options

Options outstanding as of March 31, 2017 are as follows:

			Weighted		Weighted Average
			Average		Remaining		Aggregate
			Exercise Price		Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at March 31, 2017		34,168,800	$	0.02		6.79	$	-

Exercisable at March 31, 2017		26,725,761	$	0.02		6.79	$	-

Weighted average fair value of options granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company’s common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

At March 31, 2017, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $133,323, which we expect to be recognized over the next year.

Series AA Preferred Shares

On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors. The Company recorded a special dividend and valued the Series AA Super Voting Preferred Stock at $25,000 as of March 31, 2017 and December 31, 2016.

5. Fair Value Measurements

Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines

required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.

The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: uses unobservable inputs that are not corroborated by market data.

The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. The Black Sholes Model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of March 31, 2017:

	Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of March 31, 2017
Derivative liability	$	-	$	-	$	783,579	$	783,579
Warrant liability		-		-		29,949		29,949
Commitment in excess of authorized stock		-		-		19,554		19,554
Total	$	-	$	-	$	833,082	$	833,082

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended March 31, 2017:

							Commitment
							In Excess of
	Warrant			Derivative			Authorized			Total
	Liability			Liability			Stock			Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352

Elimination of liability on conversion		-			(410,509	)		-			(410,509	)

Change in estimated fair value (1)		(55,329	)		(112,458	)		-			(167,787	)

Change in commitment in excess of authorized stock		-			-			(38,902	)		(38,902	)

Balance March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the three months ended March 31, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 249%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.06%	1.93%
Forfeitures	None	None

In computing the fair value of the derivative and warrant liability at March 31, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

SpectraScience, Inc.

Notes to Unaudited Condensed Financial Statements (continued)

6. Contingencies

Legal Proceedings

On July 7, 2016, Oakmore Opportunity Fund I LP, a variable rate noteholder of SprectraScience, filed for a preliminary judgement of $116, 500 in the Superior Court for the County of Los Angeles, case number BC622542, related to a Convertible Note. Oakmore asserts that SpectraScience breached the terms of the Convertible Note due to not having sufficient authorized shares to enable Oakmore to convert its Note with a balance of $22,500. The Company did not object to the preliminary judgement. On October 19, 2016, the Judge issued a final judgement of $521,100. The Company is retaining litigation counsel and intends to vigorously defend the amount of the judgement. The amount of ultimate liability with respect to the foregoing cannot be determined, however, the Company has established a $150,000 contingency to cover the costs of litigation and the judgement. Despite the inherent uncertainties of litigation, the Company at this time does not believe that Oakmore’s claim will have a material adverse impact on its financial condition, results of operations, or cash flows.

7. Subsequent Events

Secured Convertible Debentures

In May 2017, the Company issued a $60,000 Secured Convertible Debenture (the “Debenture”) to one accredited investor for cash consideration of $50,000. The Debenture matures in three years, carries a fixed conversion price of $0.01, and an annual interest rate of 8%. The secured interest is on all of the assets of the Company and is shared equally with a previous secured party. In addition, the Company issued a five year common stock purchase warrant exercisable into up to 3,000,000 shares of common stock at an exercise price of $0.02.

Variable Rate Convertible Debentures

In April 2017, a holder of Variable Rate Convertible Debentures with principal of $4,116 and accrued interest of $3,309 converted the remaining portion of one of their debentures into 27,000,000 shares of common stock. In addition, in May 2017, the Company entered into a variable rate note accumulating $75,000 that can be repaid for a premium ranging from 20% to 35% if paid within 180 days. If paid subsequent to 180 days, the notes are convertible into common stock at a discount to the market price.

Increase in Authorized Shares

On April 24, 2017, the Company’s shareholders approved an increase in authorized capital stock from 2 billion shares to 3 billion shares. The increase in authorized shares will become effective 20 days after the mailing of a Definitive 14C to shareholders.

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This quarterly report on Form 10-Q (the “Report”) contains forward-looking statements that are not related to historical results, including, without limitation, statements regarding our business strategy and objectives, our anticipated duration of periods of net loss, our near term operating goals, our expectations regarding the market for our products, the introduction of our products in new international markets and our beliefs with respect to opportunities and industry conditions in those markets, our beliefs about our products, product development, acquisition or licensing of complementary technologies and expectations with respect to our products’ performance and acceptance, the results of and our intentions with respect to our distribution agreement with PENTAX Europe GmbH, our beliefs about the strengths of our intellectual property portfolio, our regulatory goals and developments, anticipated clinical trials and research, our agreements with Laidlaw and other agents and their effect on our future capital resources and future financial position, our expectations with respect to stock option expense recognition, our future cash needs, the sufficiency of our working capital and our operating losses for the remainder of the current fiscal year. Although we believe that the assumptions on which these forward-looking statements are based are reasonable, there can be no assurance that such assumptions will prove to be accurate and actual results could differ materially from those discussed in the forward-looking statements. These forward-looking statements involve risks and uncertainties that could cause or contribute to such differences, including, but not limited to, changes in law or regulatory policies, unanticipated competition from other similar businesses, adverse outcomes from litigation, unexpected employee departures or disruptions, adverse market and general economic factors and other factors described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016. Such forward-looking statements are qualified in their entirety by the cautions and risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Business

SpectraScience, Inc. (the “Company,” “SpectraScience,” “we,” “our,” or “us”) develops and manufactures innovative Laser Induced Fluorescence spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without removing tissue from the body. The WavSTAT Optical Biopsy System (the “WavSTAT System”) is SpectraScience’s first product to incorporate its proprietary fluorescence technology for clinical use. The WavSTAT System carries the CE mark designation which allows for the sale and marketing in the European Union for the diagnosis of cancer. We are developing light-based diagnostics for additional indications including inflammatory bowel disease and esophageal cancer. Once these additional applications are developed we plan to self-certify for CE mark approval for sale in the European Union and then file an application with the FDA seeking permission to begin marketing for that indication for use in the United States. We believe we have a strong intellectual property portfolio that will allow us to continue to expand our WavSTAT cancer diagnosis platform to address the diagnosis of multiple cancers, utilize additional proprietary bio-photonic techniques to improve the WavSTAT’s overall diagnostic performance and ultimately allow for the detection of cancer and pre-cancer over a relatively large area of examined tissue.

Our principal executive offices are located at 11568 Sorrento Valley Rd., Suite 11, San Diego, CA 92121. We can be reached by telephone at (858) 847-0200; by fax at (858) 847-0880; or by email at info@spectrascience.com. We have a Web site at http://www.spectrascience.com. The information contained on our Web site shall not be deemed to be a part of this Report.

Plan of Operation

During the three month period ended March 31, 2017, SpectraScience carried forward on the improvements made to the WavSTAT4 in fiscal 2011 and continued working with PENTAX Europe, GmbH (“PENTAX”) and other distributors, for distribution of its products in Europe, the Middle East and Africa.

Over the next 12 months, SpectraScience intends to:

		Market and sell the WavSTAT4 Optical Biopsy System colon cancer diagnostic application through PENTAX and other distribution channels in the European Union;

		Conduct country-specific evaluation trials to demonstrate the effectiveness and cost benefit of the WavSTAT4 Optical Biopsy System in each relevant European jurisdiction;

		Coordinate the creation and publication of scientific papers and presentations related to the country-specific evaluation trials to support widespread education and adoption of the WavSTAT4;

		Pursue the introduction of the WavSTAT4 colon cancer application in other international markets, in particular China, Saudi Arabia and India;

		Begin meeting with the FDA towards the preparation and submission of a Supplemental PMA filing with the FDA and plan for additional clinical trials to support eventual approval for sale in the United States;

		Begin the design and planning for the next generation of multi-modal fluorescence and broadband spectroscopy systems at our facility in San Diego, California.

		Continue to expand and refine our intellectual property portfolio.

Results of Operations

Comparison of the Three Months Ended March 31, 2017 and 2016

	Three Months Ended March 31,						Favorable
	2017			2016			(Unfavorable)		%
Operating expenses:
Research and development	$	130,842		$	194,007		$	63,165		-32.6	%
General and administrative		279,732			307,841			28,109		-9.1	%
Sales and marketing		74,854			79,413			4,559		-5.7	%
		485,428			581,261			95,833		16.5	%

Loss from operations		(485,428	)		(581,261	)		95,833		16.5	%

Other income (expense)		(518,348	)		(1,475,073	)		956,725		-64.9	%

Net loss	$	(1,003,776	)	$	(2,056,334	)	$	1,052,558		-51.2	%

Research and Development Expenses

Research and development expenses decreased by $63,165, 32.6%, to $130,842 for the quarter ended March 31, 2017 from $194,007 for the three months ended March 31, 2016. This decrease was due to a decrease in clinical costs. We anticipate that clinical costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

General and Administrative Expenses

General and administrative expenses decreased by $28,109, 9.1%, to $279,732 for the quarter ended March 31, 2017 from $307,841 for the three months ended March 31, 2016. This decrease was due to a decrease in travel and convention costs. We anticipate that costs will increase as we proceed with our introduction of the WaveSTAT4 in Europe.

Sales and Marketing Expenses

Sales and marketing expenses decreased by $4,559, 5.7%, to $74,854 for the quarter ended March 31, 2017 from $79,413 for the quarter ended March 31, 2016. The primary reason for the decrease was a decrease in payroll costs related to the change in foreign currency values. We anticipate that sales and marketing expenses will increase as we increase our activity in Europe.

Other Income (Expense)

Other income (expense) for the quarter ended March 31, 2017 was expense of $518,348 compared to expense of $1,475,073 for the quarter ended March 31, 2016. This change was due primarily to a change in valuation of our derivative liabilities. We anticipate continued large fluctuations in other income (expense)

Liquidity and Capital Resources

	As of						Increase
	March 31, 2017			December 31, 2016			(Decrease)
Working Capital

Current assets	$	423,045		$	361,843		$	61,202
Current liabilities		11,070,084			10,801,550			268,534
Working capital deficit	$	(10,647,039	)	$	(10,439,707	)	$	207,332

Long-term debt	$	1,350,000		$	1,100,000		$	250,000

Stockholders' deficit	$	(11,043,202	)	$	(10,546,033	)	$	497,169

	Three Months Ended March 31,							Increase
		2017			2016			(Decrease)
Statements of Cash Flows Select Information

Net cash provided (used) by:
Operating activities	$	(191,880	)	$	(406,996	)	$	(215,116	)
Investing activities	$	-		$	-		$	-
Financing activities	$	288,331		$	281,288		$	7,043

	As of					Increase
		March 31, 2017		December 31, 2016		(Decrease)
Balance Sheet Select Information

Cash	$	100,001	$	3,550	$	96,451

Accounts receivable	$	-	$	950	$	(950	)

Inventory	$	97,423	$	90,594	$	6,829

Accounts payable and accrued expenses	$	3,957,746	$	3,596,779	$	360,967

Historically, the Company’s sources of cash have come from the issuance and sales of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 Systems in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.

As of March 31, 2017, the Company had a working capital deficit of $10,647,039 and cash of $100,001, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company has engaged other agents to assist it Company with raising capital and has commenced raising capital on its own. During the three months ended March 31, 2017, the Company raised $289,000, net of transaction costs of $20,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.

Off-Balance Sheet Arrangements

We have no off-balance sheet arrangements.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Not required

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)) as of the end of the period covered by this Report (the “Evaluation Date”). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date.

Changes in Internal Financial Controls

There was no change in the Company’s internal control over financial reporting that occurred during the Company’s most recently completed quarter that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II OTHER INFORMATION

Item 1. Legal Proceedings

Oakmore Suit

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in Part I, Item 1A, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2016.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Number of

Date of

Common Shares

Source of

Common Stock

Issuance

Issued

Payment

Amount

Various

529,648,837

Conversion of debt

$466,315

Common Stock Purchase Warrants

Issued With Convertible Debentures

Date of
Issuance

Number of Shares

Exercise Price

Expiration Date

3/31/2017

5,000,000

0.02

3/31/2022

Common Stock Purchase Warrants

Date of

Issued For Services

Issuance

Number of Shares

Exercise Price

Expiration Date

3/31/2017

500,000

0.02

3/31/2022

With respect to the above equity securities issuances, the Company relied on exemptions provided by Sections 4(a)(2) and 3(a)9 of the Securities Act of 1933, as amended (the “Securities Act”). No advertising or general solicitation was employed in offering the securities. The securities were issued to a limited number of persons all of whom were accredited investors as that term is defined in Rule 501 of Regulation D under the Securities Act. All were capable of analyzing the merits and risks of their investment, acknowledged in writing that they were acquiring the securities for investment and not with a view toward distribution or resale, and understood the speculative nature of their investment. All securities issued contained a restrictive legend prohibiting transfer of the shares except in accordance with federal securities laws.

Item 3. Defaults Upon Senior Securities

As of May 15, 2017, there are Unsecured Convertible Debentures with a face value of $5,998,875 held by 80 individual Holders in default. As a result, the outstanding principal amount of these Debentures, plus accrued but unpaid interest, liquidated damages and other amounts owing shall become immediately due and payable in cash at the election of the Holders. As of May 15, 2017, none of the Holders of these Debentures have elected to provide notice of default.

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

Item 6. Exhibits

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101	Financial statements from the quarterly report on Form 10-Q of the Company for the quarter ended March 31, 2016, formatted in XBRL; (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statement of Shareholders’ Equity, (iv) the Consolidated Statements of Cash Flows, and (v) the Notes to the Consolidated Financial Statements.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	SpectraScience, Inc. (Registrant)

Date: May 22, 2017	/s/ Michael P. Oliver
	Michael P. Oliver
	President and Chief Executive Officer
	(Principal executive officer)

Date: May 22, 2017	/s/ Lowell W. Giffhorn
	Lowell W. Giffhorn
	Chief Financial Officer
	(Principal financial officer and principal accounting officer)

EX-31.1 2 ex31-1.htm

Exhibit 31.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael P. Oliver, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ Michael P. Oliver
	Name:	Michael P. Oliver
	Title:	Chief Executive Officer
	Date:	May 22, 2017

EX-31.2 3 ex31-2.htm

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lowell W. Giffhorn, certify that:

1. I have reviewed this quarterly report on Form 10-Q of SpectraScience, Inc.

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

	By:	/s/ Lowell W. Giffhorn
	Name:	Lowell W. Giffhorn
	Title:	Chief Financial Officer
	Date:	May 22, 2017

EX-32.1 4 ex32-1.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael P. Oliver, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Michael P. Oliver

Michael P. Oliver

Chief Executive Officer

Date: May 22, 2017

EX-32.2 5 ex32-2.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. §1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of SpectraScience, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Lowell W. Giffhorn, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Lowell W. Giffhorn

Lowell W. Giffhorn

Chief Financial Officer

Date: May 22, 2017

EX-101.INS 6 scie-20170331.xml XBRL INSTANCE FILE 0000727672 2017-01-01 2017-03-31 0000727672 2017-05-12 0000727672 2016-12-31 0000727672 2017-03-31 0000727672 us-gaap:SeriesBPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesBPreferredStockMember 2017-03-31 0000727672 us-gaap:SeriesCPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesCPreferredStockMember 2017-03-31 0000727672 us-gaap:SeriesAPreferredStockMember 2016-12-31 0000727672 us-gaap:SeriesAPreferredStockMember 2017-03-31 0000727672 us-gaap:CommonStockMember 2016-12-31 0000727672 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0000727672 us-gaap:RetainedEarningsMember 2016-12-31 0000727672 SCIE:EngagementAgreementMember 2017-01-01 2017-03-31 0000727672 SCIE:OncoscopeIncMember 2016-12-31 0000727672 us-gaap:PreferredStockMember 2017-01-01 2017-03-31 0000727672 us-gaap:PreferredStockMember 2016-01-01 2016-03-31 0000727672 us-gaap:WarrantMember 2016-01-01 2016-03-31 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-30 0000727672 us-gaap:NotesPayableOtherPayablesMember 2014-11-01 2014-11-30 0000727672 SCIE:PromissoryNotesMember SCIE:TwoAffiliatesMember 2016-03-31 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember 2017-01-01 2017-03-31 0000727672 us-gaap:MinimumMember SCIE:ConvertibleDebentures1Member 2017-01-01 2017-03-31 0000727672 us-gaap:MaximumMember SCIE:ConvertibleDebentures1Member 2017-01-01 2017-03-31 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MinimumMember 2017-03-31 0000727672 SCIE:ConvertibleDebentures1Member us-gaap:MaximumMember 2017-03-31 0000727672 SCIE:ConvertibleDebentures1Member 2017-01-01 2017-03-31 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-03-31 0000727672 us-gaap:WarrantMember 2017-01-01 2017-03-31 0000727672 SCIE:ConversionFeatureMember 2017-01-01 2017-03-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-01-01 2017-03-31 0000727672 2016-01-01 2016-03-31 0000727672 us-gaap:WarrantMember 2016-01-01 2016-12-31 0000727672 SCIE:ConversionFeatureMember 2016-01-01 2016-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-01-01 2016-12-31 0000727672 us-gaap:WarrantMember 2016-12-31 0000727672 us-gaap:WarrantMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2015-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2015-12-31 0000727672 SCIE:ConversionFeatureMember 2016-12-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-12-31 0000727672 us-gaap:WarrantMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member 2016-12-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2017-03-31 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2016-12-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2017-01-01 2017-03-31 0000727672 us-gaap:ConvertibleDebtSecuritiesMember 2017-03-31 0000727672 SCIE:WarrantLiabilityMember 2017-01-01 2017-03-31 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2017-01-01 2017-03-31 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2017-01-01 2017-03-31 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MaximumMember 2017-03-31 0000727672 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:MinimumMember 2017-03-31 0000727672 SCIE:WarrantLiabilityMember us-gaap:MaximumMember 2017-03-31 0000727672 SCIE:WarrantLiabilityMember us-gaap:MinimumMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:WarrantLiabilityMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:WarrantLiabilityMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:WarrantLiabilityMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 SCIE:EquityIncentivePlan2011Member 2017-03-31 0000727672 SCIE:EquityIncentivePlan2011Member 2017-01-01 2017-03-31 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2017-01-01 2017-03-31 0000727672 SCIE:SeriesAASuperVotingPreferredMember 2017-03-31 0000727672 us-gaap:CommonStockMember 2017-01-01 2017-03-31 0000727672 us-gaap:CommonStockMember 2017-03-31 0000727672 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-03-31 0000727672 us-gaap:AdditionalPaidInCapitalMember 2017-03-31 0000727672 us-gaap:RetainedEarningsMember 2017-01-01 2017-03-31 0000727672 us-gaap:RetainedEarningsMember 2017-03-31 0000727672 2016-03-31 0000727672 2016-01-01 2016-12-31 0000727672 2015-12-31 0000727672 us-gaap:WarrantMember 2017-01-01 2017-03-31 0000727672 us-gaap:WarrantMember 2017-03-31 0000727672 us-gaap:WarrantMember 2017-01-01 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember 2017-01-01 2017-03-31 0000727672 SCIE:ConvertibleDebenturesMember 2016-01-01 2016-03-31 0000727672 SCIE:OptionsMember 2017-01-01 2017-03-31 0000727672 SCIE:OptionsMember 2016-01-01 2016-03-31 0000727672 SCIE:ThirdPartyMember 2017-03-31 0000727672 SCIE:ThirdPartyMember 2017-01-01 2017-03-31 0000727672 SCIE:SecuredConvertibleDebentureMember 2017-01-01 2017-03-31 0000727672 SCIE:SecuredConvertibleDebentureMember 2017-03-31 0000727672 SCIE:SecuredConvertibleDebentureMember SCIE:HolderMember 2017-01-01 2017-03-31 0000727672 SCIE:SecuredConvertibleDebentureMember SCIE:HolderMember 2017-03-31 0000727672 us-gaap:WarrantMember 2017-03-31 0000727672 SCIE:ConversionFeatureMember 2017-03-31 0000727672 SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 SCIE:SeriesAASuperVotingPreferredStockMember 2016-01-01 2016-12-31 0000727672 SCIE:EquityIncentivePlan2011Member 2016-12-31 0000727672 SCIE:ConvertibleDebenturesMember 2017-03-31 0000727672 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:CommonStockMember 2017-01-01 2017-03-31 0000727672 us-gaap:WarrantMember us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-03-31 0000727672 us-gaap:WarrantMember us-gaap:ConvertibleDebtSecuritiesMember 2017-03-31 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2016-03-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-01-01 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:WarrantLiabilityMember 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-01-01 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-01-01 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member SCIE:CommitmentInExcessOfAuthorizedStockMember 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member 2017-01-01 2017-03-31 0000727672 us-gaap:FairValueInputsLevel3Member 2017-03-31 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-07-06 2016-07-07 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-07-07 0000727672 SCIE:OakmoreOpportunityFundILPMember 2016-10-18 2016-10-19 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-04-30 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-04-01 2017-04-30 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember 2017-05-01 2017-05-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember us-gaap:MinimumMember 2017-05-01 2017-05-31 0000727672 us-gaap:SubsequentEventMember SCIE:VariableRateConvertibleDebenturesMember us-gaap:MaximumMember 2017-05-01 2017-05-31 0000727672 us-gaap:SubsequentEventMember us-gaap:MinimumMember 2017-04-24 0000727672 us-gaap:SubsequentEventMember us-gaap:MaximumMember 2017-04-24 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-02-17 2015-02-18 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-09-28 2015-10-02 0000727672 us-gaap:NotesPayableOtherPayablesMember 2015-10-02 0000727672 us-gaap:WarrantMember SCIE:HolderMember 2017-01-01 2017-03-31 0000727672 us-gaap:WarrantMember SCIE:ConsultantMember 2017-01-01 2017-03-31 0000727672 us-gaap:SubsequentEventMember SCIE:SecuredConvertibleDebentureMember 2017-05-31 0000727672 us-gaap:SubsequentEventMember SCIE:SecuredConvertibleDebentureMember 2017-05-01 2017-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SCIE:IndividualInvestors SCIE:IntellectualProperty 10-Q 2017-03-31 false --12-31 Smaller Reporting Company 2017

3550

100001

1785

127493

25850 25850 5000 5000

8836712

14133200

-10546033

-11043202

8836712

34582771

-53965519

14133200

29792890

-54969295

203444

325848

0.01

.001

0.001

2585000

500000

3000

2585000

500000

3000

2585000

500000

3000

517000

100000

106931 106931

0.01

1996000000

2000000000

3000000000

883671222

1413320059

883671222

1413320059

10551

1166

15651

-1003776

-2056334

-1003776

466314

5296488

-4830174

1166000000

-529648837

292

883671222

3000

1413320059

39837

40552

-11000

-350

-167787

887494

-950

-7061

6829

31639

-41128

-36887

180844

127720

199961

112154

-191880

-406996

309000

300000

288331

281288

96451

-125708

1000

For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Preferred Stock</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debentures</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,604,110,127</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">378,651,041</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Options</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">132,875,170</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,752,564,577</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">548,780,011</td> <td style="line-height: 115%"> </td></tr> </table>

Options outstanding as of March 31, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Remaining</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Aggregate</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Exercise Price</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Contractual</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Intrinsic</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Per Share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Term (years)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Value (1)</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; line-height: 115%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">34,168,800</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.02</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">7.03</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.02</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6.79</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercisable at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">26,725,761</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.02</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6.79</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Weighted average fair value of options granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">(1)</td> <td style="text-align: justify; line-height: 115%">These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company’s common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.</td></tr> </table>

289000

5991570

5998875

34168800

256163

40000

1752564577

3085000

132875170

548780011

111200650

1604110127

378651041

34168800

-1003776

-2056334

-1003776

-2056334

1090120075

609825530

1090120075

609825530

-0.00

0.00

-0.00

0.00

30868

37697

287031

293860

100000

82345

4116

60000

P5Y P5Y P5Y P5Y P5Y P5Y 0.09 0.0745 0.1287 0.02 50000 137982

0.10

0.20

0.00

0.10

0.08

0.20

0.05 0.10 0.00 0.10

0.01

0.099

0.01

0.0745 0.1287 0.40 0.50

5977082

480040

150000

P9M

P1Y

P3Y

0.00 0.10 0.20 0.35

6174760

6415305

320000

60000

65282 16064 -291754 -82345 132017 38767

6415305

6457122

203444 325848

819928

833082

82436

60420

495473

64428

679036

58456

82436

679036

819928

58456

620321

29949

783579

19554

29949

783579

19554

833082

630352 2842 627510 44394 697256 741650

167787

55329

112458

22378

-718458

-696080

-55329

-112458

-167787

410509

1232151

-38902 -38902 -5972 -5972

500000

5000000

1000000

133323

5500000

111200650 0.0200 0.0742

132278221

111200650

0.0765 0.0742

34168800

26725761

0.02

P6Y9M15D

783579

29949

833082

783579

29949

19554

833082

19554

P5Y

P6M

P2Y

0.074

0.0001

0.1287

0.02

2.16

2.40

2.42

2.49

0.00

0.0193

0.0079

0.0106

0.00 0.00

35000

SPECTRASCIENCE INC 1440320059 0000727672 SCIE

13767

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Fair Value Measurements Using</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Quoted Prices in</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Significant Other</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Significant</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Active Markets for</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Observable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Unobservable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Identical Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Inputs</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Inputs</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 2)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 3)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">As of March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 36%; padding-left: 10pt; line-height: 115%">Derivative liability</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">783,579</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">783,579</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Warrant liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Commitment in excess of authorized stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>

287031 293860

75000

115000

13767

0.02

0.0006

361843

423045

266749

225621

90594

97423

950

1386367

1407732

1024524

984687

196437

10801550

11070084

2278042

2458162

819928

833082

6211861

6131274

137982

112982

1318737

1499584

485428

581261

74854

79413

279732

307841

130842

194007

-485428

-581261

-518348

-1475073

-1600

-6092

-8924

-368743

6734

62530

130408 141561

167787

-887494

184709

374130

-0.00

1090120075

609825530

1. Nature of Business and Basis of Presentation   Description of Business   SpectraScience, Inc. was incorporated in the State of Minnesota on May 4, 1983 as GV Medical, Inc. In October 1992, GV Medical discontinued its prior business, refocused its development efforts and changed its name to SpectraScience, Inc. The “Company,” hereinafter, refers to SpectraScience, Inc. and its wholly owned subsidiaries Luma Imaging Corporation (“LUMA”), Spectra Science International, Inc. (“International”) and SpectraScience (UK) Limited (“SpectraUK”). Since 1996, the Company has focused primarily on developing the WavSTAT Optical Biopsy System (the “WavSTAT System”).   The Company has developed and received the European CE mark approval to market a proprietary, minimally invasive technology that optically illuminates tissue in real-time to distinguish between normal, pre-cancerous or cancerous cells without the need to remove the subject cell tissue from the body to make such determinations. The WavSTAT System operates by using cool, safe laser light to optically illuminate and analyze tissue, enabling the physician to make an instant diagnosis during endoscopy when screening for cancer, and if warranted, to begin immediate treatment during the same procedure. Beginning in December 2011, the WavSTAT 4 version of the product began to be sold in the European Union for clinical trials related to colon cancer detection. In June 2012, the Company entered into a distribution agreement with PENTAX Europe, GmbH.   On November 6, 2007, the Company acquired the assets of LUMA in an equity transaction accounted for as an acquisition of assets and now operates LUMA as a wholly-owned subsidiary of the Company. LUMA had acquired the assets from a predecessor company that had developed, and received FDA approval for, a non-invasive diagnostic imaging system that can detect cervical cancer precursors and which utilizes an underlying technology that is similar to that of the WavSTAT System. The addition of the LUMA technology to the Company’s existing WavSTAT System technology provides the Company with a broad suite of fluorescence-based intellectual property and know-how. During the fiscal year ended December 31, 2010, the Company wrote off the remaining fair value of the LUMA inventory in order to focus on the continued development and marketing of the WavSTAT System. The Company retained the intellectual property of LUMA for use in the development of future generations of the WavSTAT System.   The transaction was accounted for as an acquisition of assets that included intellectual property, inventory and equipment. The intellectual property consisted of a total of 34 issued U.S. patents and 28 additional patent applications.   Basis of Presentation   The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q as they are prescribed for smaller reporting companies. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the three month period ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. These statements should be read in conjunction with the financial statements and related notes, which are included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016.   Going Concern   Historically, the Company’s sources of cash have come from the issuance and sale of equity securities and debentures. The Company’s historical cash outflows have been primarily used for operating activities including research, development, administrative and sales activities. Fluctuations in the Company’s working capital due to timing differences of its cash receipts and cash disbursements also impact its cash flow. The Company expects to incur significant additional operating losses through at least the end of 2017, as it completes proof-of-concept trials, conducts outcome-based clinical studies and increases sales and marketing efforts to commercialize the WavSTAT4 System in Europe. If the Company does not receive sufficient funding, there is substantial doubt that the Company will be able to continue as a going concern. The Company may incur unknown expenses or may not be able to meet its revenue forecast, and one or more of these circumstances would require the Company to seek additional capital. The Company may not be able to obtain equity capital or debt funding on terms that are acceptable. Even if the Company receives additional funding, such proceeds may not be sufficient to allow the Company to sustain operations until it becomes profitable and begins to generate positive cash flows from operations.   As of March 31, 2017, the Company had a working capital deficit of $10,647,039 and cash of $100,001, compared to a working capital deficit of $10,439,707 and cash of $3,550 as of December 31, 2016. The Company uses agents to assist it with raising capital and has commenced raising capital on its own. During the three months ended March 31, 2017, the Company raised $289,000, net of transaction costs of $20,000, under these agreements. However, if the Company does not receive additional funds in a timely manner, the Company could be in jeopardy as a going concern. The Company may not be able to find alternative capital or raise capital or debt on terms that are acceptable. Management believes that if the events defined in the Engagement Agreements occur as expected, or if the Company is otherwise able to raise a similar level of funds, such proceeds will be sufficient to allow the Company to sustain operations until it attains profitability and positive cash flows from operations. However, the Company may incur unknown expenses or may not be able to meet its revenue expectations requiring it to seek additional capital. In such event, the Company may not be able to find capital or raise capital or debt on terms that are acceptable.   The holders of Convertible Debentures control the conversion of the Convertible Debentures and certain of the Convertible Debentures were not converted at their maturity constituting a potential default on the matured, but unconverted, Convertible Debentures. In the event of such default, principal, accrued interest and other related costs are immediately due and payable in cash. As of March 31, 2017, Convertible Debentures with a face value of $5,998,875 held by 80 individual investors are in default. None of these investors have served notice of default on the Convertible Debentures held by them.   The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The financial statements do not include any adjustments relating to the recoverability and classification of assets or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

2. Summary of Significant Accounting Policies   Revenue recognition   The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.   Consolidation   The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.   Risks and Uncertainties   The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.   Use of Estimates   The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.   Inventory Valuation   The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.   Valuation of Long-lived Assets   The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.   Variable Conversion Rate Debentures   Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.   Over Commitment of Shares   Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.   Stock-Based Compensation   The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.   The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards   granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.   All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.   As of March 31, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At March 31, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 26,725,761 shares were exercisable. Awards under the Company’s EIP generally vest over four years.   The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the three month periods ended March 31, 2017 and 2016.   Earnings (Loss) Per Share   Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.   For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Preferred Stock</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debentures</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,604,110,127</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">378,651,041</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Options</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">132,875,170</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,752,564,577</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">548,780,011</td> <td style="line-height: 115%"> </td></tr> </table>   The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="text-align: center; line-height: 115%">Three Months Ended</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Numerator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; line-height: 115%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,003,776</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(2,056,334</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Net loss for diluted earnings per share</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(1,003,776</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(2,056,334</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Weighted average basic shares outstanding</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator for diluted earnings per share-Adjusted weighted average shares</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Income (loss) per share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Basic</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Diluted</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> </table>   Inventory   Inventory consisted of the following at March 31, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 51%; line-height: 115%">Raw materials</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">256,163</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 23%; text-align: right; line-height: 115%">256,163</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Finished goods</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">37,697</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,868</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">293,860</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">287,031</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Reserve for obsolescence</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">293,860</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">287,031</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less long-term portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">196,437</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">196,437</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">97,423</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">90,594</td> <td style="line-height: 115%"> </td></tr> </table>   During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.   Recently Adopted and Issued Accounting Pronouncements   In August 2014, the FASB issued FASB ASU2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. FASB ASU 2014-15 changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. These changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. These changes became effective for the Company for the 2016 annual period. Management has evaluated the impact of the adoption of these changes and has determined there will be no material impact on the consolidated financial statements. Subsequent to adoption, this guidance will need to be applied by management at the end of each annual period and interim period therein to determine what, if any, impact there will be on the consolidated financial statements in a given reporting period.   In April 2015, the FASB issued ASU No 2015-3, Simplifying the Presentation of Debt Issuance Costs. This update changes the presentation of debt issuance costs in the balance sheet. ASU 2015-03 requires debt issuance costs related to a recognized debt obligation to be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability rather than being presented as an asset. Amortization of debt issuance costs will continue to be reported as interest expense. In August 2015, the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements”. This ASU clarified guidance in ASC 2015-03 stating that the SEC staff would not object to a company presenting debt issuance costs related to a line-of-credit arrangement on the balance sheet as a deferred asset, regardless of whether there were any outstanding borrowings at period-end. This update is effective for annual and interim periods beginning after December 15, 2015, which required us to adopt these provisions in the first quarter of 2016. This update was applied on a retrospective basis, wherein the balance sheet of each period presented was adjusted to reflect the effects of applying the new guidance. The adoption of this guidance did not have a material impact on our consolidated financial statements.   In November 2015, the FASB issued ASU No 2015-17, Income Taxes (Topic 740). The amendments in ASU 2015-17 change the requirements for the classification of deferred taxes on the balance sheet. Currently, GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, the amendments in this ASU require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The pronouncement is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2016. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. The Company has early adopted this pronouncement for the fiscal reporting period ended December 31, 2016, and has reclassified the presentation of deferred income taxes in the prior period to conform with the current year classification in the consolidated balance sheets. As a result of the Company having recognized a valuation reserve for the entire deferred tax liability balance at March 31, 2017 and December 31, 2016, there is no impact of the presentation of deferred income taxes in our financial statements.   In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.   Reclassifications   Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

3. Liabilities   Note Payable   In November 2014, the Company issued for cash of $100,000 an unsecured note payable and a five-year warrant with an exercise price of $0.09 per share for the purchase of up to 50,000 shares of common stock. The terms of the note were a repayment of $115,000 if paid by February 18, 2015 and, if paid thereafter, the principal balance of the note was to be increased to $137,982 as of October 1, 2015 and interest accrues at 20% from October 1, 2015 until paid. During the three months ended March 31, 2017, $25,000 principal of this note was assigned to a third party who paid a like amount to the holder of the note. The balance of the note outstanding at March 31, 2017, $112,982, continues to accrue interest at 20%.   Notes Payable- Related Parties   During the three months ended March 31, 2016, two affiliates of the Company advanced to the Company cash in an accumulated amount of $35,000 in exchange for six-month 10% promissory notes. The balance of the notes remains $35,000 at March 31, 2017.   Convertible Debentures   As of March 31, 2017, the Company has issued and outstanding fixed rate Convertible Debentures (“Debentures”) with original terms of three months to one year, an interest rate ranging from 10-20% per year and an original issue discount ranging from 5% to 10% which, at the option of the holder, may convert into common stock at initial conversion prices ranging from $0.01 to $0.099 per share.   The Debentures were issued with detachable five year cashless Holders Warrants that allow the holders to purchase one share of stock for each two shares available under the converted Debentures at an exercise price ranging from $0.02 to $0.1287 per share. In addition, the Company issued five-year cashless Agent Warrants equal to 10% of the total number of shares issuable under the Debentures and Holders Warrants at exercise prices ranging from $0.0745 to $0.1287 per share. For debentures issued through March 31, 2013, at the option of the Debenture holder, the terms of the Debentures and Holders Warrants are subject to an exchange feature in the event that the Company issues securities with terms more favorable than those of the then outstanding Debentures and Holders Warrants. Debentures issued subsequent to March 31, 2013 do not contain such an exchange clause. During the three months ended March 31, 2017, Debentures with an accumulated principal balance of $150,000 and $13,767 of accrued interest were assigned to a third party note holder. The new notes contain variable conversion rates discussed below. The gross amount of Debentures with fixed conversion rates outstanding is $5,977,082 as of March 31, 2017.   During the three months ended March 31, 2017, the Company has issued and outstanding Convertible Debentures (“Variable Debentures”) with original terms of 9 months to one year, interest rates ranging from 0-10% per year and original issue discounts ranging from 0-10% which contain variable conversion rates ranging from discounts of 40-50% of the Company’s common stock based on the Company’s common stock trading prices ranging from 10-25 days previous to conversion. The Variable Debentures contain prepayment options which enable the Company to prepay the notes for periods of 0-180 days subsequent to issuance at premiums ranging from 0-50%. The gross amount of Variable Debentures outstanding is $480,040 as of March 31, 2017.   As of March 31, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="text-align: center; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Balance at beginning of period</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">6,415,305</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">6,174,760</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Issuance of debentures for cash</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">60,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">320,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Issuance of debentures for services</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">10,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">15,000</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Issuance of debentures for forbearance</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">16,064</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">65,282</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Debentures repaid in cash</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(669</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Debentures converted to common stock</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(82,345</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(291,754</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Debentures exchanged for new debentures</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">38,767</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">132,017</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debt</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6,457,122</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6,415,305</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Less unamortized costs of financing</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">325,848</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">203,444</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debt, net of unamortized costs</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,131,274</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">6,211,861</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debt in default</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">5,998,875</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">5,991,570</td> <td style="line-height: 115%"> </td></tr> </table>   Secured Convertible Note   During the three months ended March 31, 2017, the Company issued for cash of $250,000 Secured Convertible Debentures (the “Secured Debentures”) to two accredited investors. The terms of the Debentures are for three years, a conversion price of $0.01 per share and an annual interest rate of 8%. The secured interest is on all of the assets of the Company. In addition, the Company issued to the holder of $100,000 Secured Debentures, a five year common stock purchase warrant to purchase up to 5,000,000 shares of common stock with an exercise price of $0.02 per share. The value of this warrant, $292, was determined using the Black Sholes Method and was reflected as a discount to the Secured Debenture.   Derivative Liability   Since the Company issued Convertible Debentures which included Holders Warrants, Agent Warrants and a conversion option that includes a possible exchange feature in the event of a future financing on terms more favorable than those of the existing warrants and debentures, this results in the warrants and conversion feature of the debentures being recorded as a liability and measured at   fair value. In addition, outstanding Variable Debentures contain variable conversion rates based on unknown future prices of the Company’s common stock resulting in a conversion feature. The Company measures these warrants and conversion features using the Black Scholes Model. The period over which the Company will be required to evaluate the fair value of the warrants is approximately five years and the period over which the Company will be required to evaluate the fair value of the conversion features are six to twelve months or conversion.   The assumptions used in determining fair value represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management’s judgment. As a result, if factors change, including changes in the market value of the Company’s common stock, managements’ assessment of the probability of a more favorably priced future financing or significant fluctuations in the volatility of the trading market for the Company’s common stock, the Company’s fair value estimates could be materially different in the future.   The Company computes the fair value of the derivative liability at each reporting period and the change in the fair value is recorded as non-cash expense or non-cash income. The key component in the value of the derivative liability is the Company’s stock price, which is subject to significant fluctuation and is not under the Company’s control. Therefore, the resulting effect on net loss is subject to significant fluctuation and will continue to be so until the Company’s Debentures, which the convertible feature is associated with, are converted into common stock or paid in full with cash. Assuming all other fair value inputs remain constant, the Company will record non-cash expense when its stock price increases and non-cash income when its stock price decreases.   In addition, since the number of shares issuable under the Variable Debentures are undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock. For the three months ended March 31, 2017, the Company determined that it was over committed to the number of shares issuable on the exercise of outstanding debentures, stock options and warrants for approximately 1,166,000,000 shares.   As of March 31, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Commitment</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">In Excess of</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Authorized</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Feature</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Stock</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; line-height: 115%">Balance at January 1, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">60,420</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">495,473</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">64,428</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">620,321</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">44,394</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">697,256</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">741,650</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Change in fair value at year end</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(22,378</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">718,458</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">696,080</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(1,232,151</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(1,232,151</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Over commitment of stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(5,972</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(5,972</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance at December 31, 2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">82,436</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">679,036</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">58,456</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">819,928</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,842</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">627,510</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">630,352</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Change in fair value at year end</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(55,329</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(112,458</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(167,787</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Over commitment of stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">783,579</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>   Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

4. Shareholders’ Deficit   Common Stock   During the three months ended March 31, 2017, holders of Convertible Debentures with a face value of $82,345 and accrued interest of $6,074 converted their debentures into 529,648,837 shares of common stock. In addition, associated with these debentures, the Company recorded a gain on extinguishment of debt of $15,651.   Warrants   During the three months ended March 31, 2017, in conjunction with the sale of Convertible Debentures, the Company issued a five-year common stock purchase warrant to acquire up to 5,000,000 shares to holders of the Debentures. In addition, the Company issued a five-year common stock purchase warrant to acquire up to 500,000 shares to an agent who assisted in this financing. These warrants have an exercise price of $0.02 per share. The value of the warrants was determined using the Black Sholes Model. The value of the warrant issued to the note holder, $2,925, was reflected as a discount to the note and the value of the warrant issued to the agent, $292, was reflected as a non-cash operating expense.   In March 2016, the Company issued a warrant exercisable into up to 1,000,000 shares of common stock in exchange for services provided by a consultant. The value of these warrants, $1,652, was determined using the Black Scholes Model and was included as non-cash expenses and additional paid-in capital during the three months ended March 31, 2016.     The balance of all warrants outstanding as of March 31, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Exercise</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Fair</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Price</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Value</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 33%; line-height: 115%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 19%; text-align: right; line-height: 115%">132,278,221</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 19%; text-align: right; line-height: 115%">0.0765</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 19%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5,500,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0200</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0006</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(26,577,571</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0745</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0742</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercisable at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0742</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>   Stock Options   Options outstanding as of March 31, 2017 are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Remaining</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Aggregate</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Exercise Price</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Contractual</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Intrinsic</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Options</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Per Share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Term (years)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Value (1)</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; line-height: 115%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">34,168,800</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">0.02</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%">7.03</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 13%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.02</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6.79</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercisable at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">26,725,761</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.02</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">6.79</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Weighted average fair value of options granted during the period</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table>   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 24px; text-align: justify; line-height: 115%">(1)</td> <td style="text-align: justify; line-height: 115%">These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company’s common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.</td></tr> </table>   At March 31, 2017, total unrecognized estimated employee compensation cost related to non-vested stock options granted prior to that date is $133,323, which we expect to be recognized over the next year.   Series AA Preferred Shares   On April 15, 2016, the Board of Directors of the Company authorized an amendment to the Company’s Articles of Incorporation, as amended (the “Articles of Incorporation”), in the form of a Certificate of Designation that authorized the issuance of up to three thousand (3,000) shares of a new series of preferred stock, par value $0.001 per share, designated “Series AA Super Voting Preferred Stock,” for which the board of directors established the rights, preferences and limitations thereof.   Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company. The holders are restricted from voting the preferred shares for any proposal on the election of directors. The Company recorded a special dividend and valued the Series AA Super Voting Preferred Stock at $25,000 as of March 31, 2017 and December 31, 2016.

5. Fair Value Measurements   Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines required disclosures. It clarifies that fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants in the market in which the reporting entity transacts business.   The Company’s balance sheet contains derivative and warrant liabilities that are recorded at fair value on a recurring basis. The three-level valuation hierarchy for disclosure of fair value is as follows:   Level 1: uses quoted market prices in active markets for identical assets or liabilities.   Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.   Level 3: uses unobservable inputs that are not corroborated by market data.   The fair value of the Company’s recorded derivative and warrant liabilities is determined based on unobservable inputs that are not corroborated by market data, which require a Level 3 classification. The Black Sholes Model was used to determine the fair value with similar assumptions to those described under “Stock-Based Compensation”. The Company records derivative and warrant liabilities on the condensed consolidated balance sheets at fair value with changes in fair value recorded in the condensed consolidated statements of operation.   The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="14" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Fair Value Measurements Using</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Quoted Prices in</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Significant Other</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Significant</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Active Markets for</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Observable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Unobservable</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Identical Assets</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Inputs</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Inputs</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 2)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">(Level 3)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">As of March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 36%; padding-left: 10pt; line-height: 115%">Derivative liability</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">-</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">783,579</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">783,579</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Warrant liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Commitment in excess of authorized stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>   The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Commitment</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">In Excess of</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Warrant</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Derivative</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Authorized</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Stock</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; line-height: 115%">Balance December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">82,436</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">679,036</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">58,456</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">819,928</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,842</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">627,510</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">630,352</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Change in estimated fair value (1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(55,329</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(112,458</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(167,787</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Change in commitment in excess of authorized stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">783,579</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>   (1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”   Management used the following inputs to value the Derivative and Warrant Liabilities for the three months ended March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Derivative Liability</td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrant Liability</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 115%">Expected term</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 28%; text-align: center; line-height: 115%">6 months to 2 years</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 28%; text-align: center; line-height: 115%">5 years</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Exercise price</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">$0.0001 - $0.074</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">$0.02 - $0.1287</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Expected volatility</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">216% to 240%</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">242% to 249%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expected dividends</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Risk-free interest rate</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">0.79% to 1.06%</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">1.93%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeitures</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td></tr> </table>   In computing the fair value of the derivative and warrant liability at March 31, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

7. Subsequent Events   Secured Convertible Debentures   In May 2017, the Company issued a $60,000 Secured Convertible Debenture (the “Debenture”) to one accredited investor for cash consideration of $50,000. The Debenture matures in three years, carries a fixed conversion price of $0.01, and an annual interest rate of 8%. The secured interest is on all of the assets of the Company and is shared equally with a previous secured party. In addition, the Company issued a five year common stock purchase warrant exercisable into up to 3,000,000 shares of common stock at an exercise price of $0.02.   Variable Rate Convertible Debentures   In April 2017, a holder of Variable Rate Convertible Debentures with principal of $4,116 and accrued interest of $3,309 converted the remaining portion of one of their debentures into 27,000,000 shares of common stock. In addition, in May 2017, the Company entered into a variable rate note accumulating $75,000 that can be repaid for a premium ranging from 20% to 35% if paid within 180 days. If paid subsequent to 180 days, the notes are convertible into common stock at a discount to the market price.   Increase in Authorized Shares   On April 24, 2017, the Company’s shareholders approved an increase in authorized capital stock from 2 billion shares to 3 billion shares. The increase in authorized shares will become effective 20 days after the mailing of a Definitive 14C to shareholders.   Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

As of March 31, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Commitment</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">In Excess of</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Authorized</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Feature</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Stock</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 40%; line-height: 115%">Balance at January 1, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">60,420</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">495,473</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">64,428</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 12%; text-align: right; line-height: 115%">620,321</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">44,394</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">697,256</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">741,650</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Change in fair value at year end</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(22,378</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">718,458</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">696,080</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(1,232,151</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(1,232,151</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Over commitment of stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(5,972</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(5,972</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance at December 31, 2016</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">82,436</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">679,036</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">58,456</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">819,928</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,842</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">627,510</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">630,352</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Change in fair value at year end</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(55,329</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(112,458</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(167,787</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Over commitment of stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">783,579</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>

The balance of all warrants outstanding as of March 31, 2017 is as follows:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Weighted</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Average</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Exercise</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Fair</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Price</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Value</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 33%; line-height: 115%">Outstanding at January 1, 2017</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 19%; text-align: right; line-height: 115%">132,278,221</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 19%; text-align: right; line-height: 115%">0.0765</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 19%; text-align: right; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Granted</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">5,500,000</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0200</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0006</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Cancelled</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(26,577,571</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0745</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Exercised</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Outstanding at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0742</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Exercisable at March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%">$</td> <td style="text-align: right; line-height: 115%">0.0742</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> </table> 10439707 10647039

1100000

1350000

30850 30850 80

40001

116500

34582771

29792890

-53965519

-54969295

1386367

1407732

385102

94329

40001

-38902

131504

35000

669

20000

53712

88419

75812

25000

6. Contingencies   Legal Proceedings   On July 7, 2016, Oakmore Opportunity Fund I LP, a variable rate noteholder of SprectraScience, filed for a preliminary judgement of $116, 500 in the Superior Court for the County of Los Angeles, case number BC622542, related to a Convertible Note. Oakmore asserts that SpectraScience breached the terms of the Convertible Note due to not having sufficient authorized shares to enable Oakmore to convert its Note with a balance of $22,500. The Company did not object to the preliminary judgement. On October 19, 2016, the Judge issued a final judgement of $521,100. The Company is retaining litigation counsel and intends to vigorously defend the amount of the judgement. The amount of ultimate liability with respect to the foregoing cannot be determined, however, the Company has established a $150,000 contingency to cover the costs of litigation and the judgement. Despite the inherent uncertainties of litigation, the Company at this time does not believe that Oakmore’s claim will have a material adverse impact on its financial condition, results of operations, or cash flows.

34 28

20000

40000000

112982

25000

35000

5000000

6074

529648837

25000

-26577571 0.0745 P7Y11D

-410509

-38902 -38902

22500

521100

150000

3309

Revenue recognition   The Company recognizes revenues when persuasive evidence of an arrangement exists, delivery has occurred or services have been rendered, the price is fixed or determinable and collectability is reasonably assured. Revenue from the sale of the Company’s products is generally recognized when title and risk of loss transfers to the customer, the terms of which are generally free on board shipping point. The Company uses customer purchase orders to determine the existence of an arrangement. The Company uses shipping documents and third-party proof of delivery to verify that title has transferred. The Company assesses whether the price is fixed or determinable based upon the terms of the agreement associated with the transaction. To determine whether collection is probable, the Company assesses a number of factors, including past transaction history with the customer and the creditworthiness of the customer.

The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="text-align: center; line-height: 115%">Three Months Ended</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Numerator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; line-height: 115%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,003,776</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(2,056,334</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Net loss for diluted earnings per share</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(1,003,776</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(2,056,334</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Weighted average basic shares outstanding</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator for diluted earnings per share-Adjusted weighted average shares</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Income (loss) per share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Basic</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Diluted</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> </table>

Inventory consisted of the following at March 31, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">December 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 51%; line-height: 115%">Raw materials</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 20%; text-align: right; line-height: 115%">256,163</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 23%; text-align: right; line-height: 115%">256,163</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Finished goods</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">37,697</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">30,868</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">293,860</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">287,031</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Reserve for obsolescence</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">293,860</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">287,031</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Less long-term portion</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">196,437</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">196,437</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">97,423</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">90,594</td> <td style="line-height: 115%"> </td></tr> </table>

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Commitment</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">In Excess of</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Warrant</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Derivative</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Authorized</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="text-align: center; line-height: 115%">Total</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Stock</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Liability</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 36%; line-height: 115%">Balance December 31, 2016</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">82,436</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">679,036</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">58,456</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%">$</td> <td style="width: 13%; text-align: right; line-height: 115%">819,928</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Liability on issuance of debt and warrants</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">2,842</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">627,510</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">630,352</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Elimination of liability on conversion</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(410,509</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Change in estimated fair value (1)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(55,329</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(112,458</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">(167,787</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Change in commitment in excess of authorized stock</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">-</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(38,902</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Balance March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">29,949</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">783,579</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">19,554</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">833,082</td> <td style="line-height: 115%"> </td></tr> </table>   (1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the three months ended March 31, 2017:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center; line-height: 115%"> </td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Derivative Liability</td> <td style="text-align: center; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">Warrant Liability</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 42%; line-height: 115%">Expected term</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 28%; text-align: center; line-height: 115%">6 months to 2 years</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 28%; text-align: center; line-height: 115%">5 years</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Exercise price</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">$0.0001 - $0.074</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">$0.02 - $0.1287</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Expected volatility</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">216% to 240%</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">242% to 249%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Expected dividends</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Risk-free interest rate</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">0.79% to 1.06%</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">1.93%</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Forfeitures</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td> <td style="line-height: 115%"> </td> <td style="text-align: center; line-height: 115%">None</td></tr> </table>

2100 137982 250000 100000

292

2925

1652

292

27000000

15000 10000 -669

Consolidation   The accompanying consolidated financial statements include the accounts of SpectraScience, Inc. and its wholly-owned subsidiaries LUMA, International and Spectra UK. All significant intercompany balances and transactions have been eliminated in consolidation.

Risks and Uncertainties   The Company operates in an industry that is subject to intense competition, government regulation and rapid technological change. The Company’s operations are subject to significant risk and uncertainties, including financial, operational, technological, regulatory and other risks associated with a short history of product sales, including the potential risk of business failure.

Use of Estimates   The Company prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, which requires management to make estimates and assumptions that affect the amounts reported in the financial statements and disclosures made in the accompanying notes to the financial statements. Significant estimates made by management include, among others, realization of long-lived assets including intangible assets, assumptions used to value stock options, assumptions used to value the common stock issued and assumptions related to the determination of the fair value of the derivative components associated with the Company’s Convertible Debentures. Actual results could differ from those estimates.

Inventory Valuation   The Company states its inventory at the lower of cost or market value, determined on a specific cost basis. The Company provides inventory allowances when conditions indicate that the selling price could be less than cost due to obsolescence and reductions in estimated future demand. The Company balances the need to maintain strategic inventory levels with the risk of obsolescence due to changing technology and customer demand levels. Unfavorable changes in market conditions may result in a need for additional inventory reserves that could adversely impact the Company’s gross margins. Conversely, favorable changes in demand could result in higher gross margins when the Company sells products.

Valuation of Long-lived Assets   The Company’s long-lived assets consist of property and equipment and intangible assets. Equipment is carried at cost and is depreciated over the estimated useful lives of the assets, which are generally two to three years, and leasehold improvements are amortized over the lesser of the lease term or the estimated useful lives of the improvements. The straight-line method is used for depreciation and amortization. Intangible assets consist of patents, which are amortized using the straight-line method over the estimated useful lives of the patents. The Company does not capitalize external legal costs and filing fees associated with obtaining patents on its new discoveries. Acquired intellectual property is recorded at cost and is amortized over its estimated useful life. The Company believes the useful lives assigned to these assets are reasonable. The Company assesses the recoverability of long-lived assets whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. These computations utilize judgments and assumptions inherent in management’s estimate of future cash flows to determine recoverability of these assets. If management’s assumptions about these assets were to change as a result of events or circumstances, the Company may be required to record an impairment loss.

Variable Conversion Rate Debentures   Starting in 2015, the Company entered into convertible debentures with floating exercise prices discounted to market prices. As a result, a significant number of shares were either issued or may be issued at deeply discounted variable conversion prices. The downward pressure placed on the Company’s stock as a result of these conversions can be classified as “death spirals” since the investors have no incentive to maintain a stable stock price. The Company accounts for these debentures as derivative liabilities which means the debentures are revalued at the end of each period and gains and losses are recognized at the issuance of the debentures and on the conversion of the debentures.

Over Commitment of Shares   Since the number of shares issuable under convertible debentures with floating exercise prices is undeterminable, the Company may be required to issue shares in excess of the number of shares authorized by its shareholders. As a result, when the Company determines that is does not have sufficient shares to meet the obligations of derivative unexercised debentures, warrants and options, the derivatives must be valued using the Black Scholes Option Pricing method and a liability is recorded as though the obligations would be settled using some means other than stock.

Stock-Based Compensation   The Company accounts for stock-based compensation under the provisions of FASB ASC Topic 718, Compensation—Stock Compensation (“ASC 718”), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. The Company estimates the fair value of stock-based awards on the date of grant using the Black Scholes option-pricing model (the “Black-Scholes Model”). The value of the portion of the award that is ultimately expected to vest is recognized as expense over the requisite service periods using the straight-line method. The Company estimates forfeitures at the time of grant and revises its estimate in subsequent periods if actual forfeitures differ from those estimates.   The Company accounts for stock-based compensation awards to non-employees in accordance with FASB ASC Topic 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards   granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.   All issuances of stock options or other equity instruments to employees and non-employees as the consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded in expense and additional paid-in capital in shareholders’ equity over the applicable service periods using variable accounting through the vesting dates based on the fair value of the options at the end of each reporting period.   As of March 31, 2017, the Company had one stock-based employee compensation plan under which it makes grants, the 2011 Equity Incentive Plan (the “EIP”). The EIP provides for the grant of incentive stock options (“ISOs”), nonqualified stock options (“NQSOs”) and restricted stock awards to full-time employees (who may also be directors) and NQSOs and restricted stock awards to non-employee directors, consultants, customers, vendors or providers of services. The exercise price of any ISO may not be less than the fair market value of the common stock on the date of grant and the term shall not exceed ten years. The amount reserved under the 2011 EIP is 40,000,000 shares of common stock. At March 31, 2017, the Company had options outstanding exercisable into up to 34,168,800 shares of stock under the EIP of which up to 26,725,761 shares were exercisable. Awards under the Company’s EIP generally vest over four years.   The fair value of options granted are estimated at the date of grant using a Black Scholes Model which includes several variables including expected life, risk free interest rate, expected stock price volatility, stock option exercise patterns and expected dividend yield. The Company also must estimate forfeitures for employee stock options. There were no stock options granted during the three month periods ended March 31, 2017 and 2016.

Earnings (Loss) Per Share   Basic loss per share is computed by dividing loss available to common shareholders by the weighted-average number of common shares outstanding. Diluted loss per share is computed similar to basic loss per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. Common equivalent shares are excluded from the computation if their effect is anti-dilutive.   For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31, 2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%; line-height: 115%">Preferred Stock</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 20%; text-align: right; line-height: 115%">3,085,000</td> <td style="width: 1%; line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Convertible debentures</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,604,110,127</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">378,651,041</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Options</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">34,168,800</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Warrants</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">111,200,650</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; line-height: 115%"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">132,875,170</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Total</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,752,564,577</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">548,780,011</td> <td style="line-height: 115%"> </td></tr> </table>   The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:   <table cellspacing="0" cellpadding="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="text-align: center; line-height: 115%">Three Months Ended</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">March 31,</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2017</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center; line-height: 115%">2016</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td colspan="2" style="line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Numerator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="width: 54%; line-height: 115%">Net loss for basic earnings per share</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(1,003,776</td> <td style="width: 1%; line-height: 115%">)</td> <td style="width: 1%; line-height: 115%"> </td> <td style="width: 1%; border-bottom: black 1.5pt solid; line-height: 115%">$</td> <td style="width: 20%; border-bottom: black 1.5pt solid; text-align: right; line-height: 115%">(2,056,334</td> <td style="width: 1%; line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Net loss for diluted earnings per share</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(1,003,776</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(2,056,334</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator:</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%">Weighted average basic shares outstanding</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Denominator for diluted earnings per share-Adjusted weighted average shares</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">1,090,120,075</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">609,825,530</td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="line-height: 115%">Income (loss) per share</td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="line-height: 115%"> </td> <td style="text-align: right; line-height: 115%"> </td> <td style="line-height: 115%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt; line-height: 115%">Basic</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-left: 10pt; line-height: 115%">Diluted</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td> <td style="line-height: 115%"> </td> <td style="border-bottom: black 2.25pt double; line-height: 115%">$</td> <td style="border-bottom: black 2.25pt double; text-align: right; line-height: 115%">(0.00</td> <td style="line-height: 115%">)</td></tr> </table>

Inventory   Inventory consisted of the following at March 31, 2017 and December 31, 2016:   <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">March 31, 2017</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center">December 31, 2016</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 51%">Raw materials</td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 20%; text-align: right">256,163</td> <td style="width: 1%"> </td> <td style="width: 1%"> </td> <td style="width: 1%">$</td> <td style="width: 23%; text-align: right">256,163</td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Finished goods</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">37,697</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">30,868</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right">293,860</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">287,031</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Reserve for obsolescence</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td> </td> <td> </td> <td> </td> <td style="text-align: right">293,860</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">287,031</td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt">Less long-term portion</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">196,437</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right">196,437</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">97,423</td> <td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: black 2.25pt double">$</td> <td style="border-bottom: black 2.25pt double; text-align: right">90,594</td> <td style="padding-bottom: 2.5pt"> </td></tr> </table>   During the year ended December 31, 2016, the Company purchased the inventory of Oncoscope, Inc. from the Trustee of Ondoscope’s bankruptcy proceeding for a total of $40,000. This amount, net of amounts sold of $2,100, has been included in raw materials.

Recently Adopted and Issued Accounting Pronouncements   In August 2014, the FASB issued FASB ASU2014-15, Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern. FASB ASU 2014-15 changes to the disclosure of uncertainties about an entity’s ability to continue as a going concern. These changes require an entity’s management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that financial statements are issued. Substantial doubt is defined as an indication that it is probable that an entity will be unable to meet its obligations as they become due within one year after the date that financial statements are issued. If management has concluded that substantial doubt exists, then the following disclosures should be made in the financial statements: (i) principal conditions or events that raised the substantial doubt, (ii) management’s evaluation of the significance of those conditions or events in relation to the entity’s ability to meet its obligations, (iii) management’s plans that alleviated the initial substantial doubt or, if substantial doubt was not alleviated, management’s plans that are intended to at least mitigate the conditions or events that raise substantial doubt, and (iv) if the latter in (iii) is disclosed, an explicit statement that there is substantial doubt about the entity’s ability to continue as a going concern. These changes became effective for the Company for the 2016 annual period. Management has evaluated the impact of the adoption of these changes and has determined there will be no material impact on the consolidated financial statements. Subsequent to adoption, this guidance will need to be applied by management at the end of each annual period and interim period therein to determine what, if any, impact there will be on the consolidated financial statements in a given reporting period.   In April 2015, the FASB issued ASU No 2015-3, Simplifying the Presentation of Debt Issuance Costs. This update changes the presentation of debt issuance costs in the balance sheet. ASU 2015-03 requires debt issuance costs related to a recognized debt obligation to be presented in the balance sheet as a direct deduction from the carrying amount of the related debt liability rather than being presented as an asset. Amortization of debt issuance costs will continue to be reported as interest expense. In August 2015, the FASB issued ASU 2015-15, “Presentation and Subsequent Measurement of Debt Issuance Costs Associated with Line-of-Credit Arrangements”. This ASU clarified guidance in ASC 2015-03 stating that the SEC staff would not object to a company presenting debt issuance costs related to a line-of-credit arrangement on the balance sheet as a deferred asset, regardless of whether there were any outstanding borrowings at period-end. This update is effective for annual and interim periods beginning after December 15, 2015, which required us to adopt these provisions in the first quarter of 2016. This update was applied on a retrospective basis, wherein the balance sheet of each period presented was adjusted to reflect the effects of applying the new guidance. The adoption of this guidance did not have a material impact on our consolidated financial statements.   In November 2015, the FASB issued ASU No 2015-17, Income Taxes (Topic 740). The amendments in ASU 2015-17 change the requirements for the classification of deferred taxes on the balance sheet. Currently, GAAP requires an entity to separate deferred income tax liabilities and assets into current and noncurrent amounts in a classified statement of financial position. To simplify the presentation of deferred income taxes, the amendments in this ASU require that deferred tax liabilities and assets be classified as noncurrent in a classified statement of financial position. The pronouncement is effective for fiscal years and interim periods within those fiscal years beginning after December 15, 2016. Earlier application is permitted for all entities as of the beginning of an interim or annual reporting period. The Company has early adopted this pronouncement for the fiscal reporting period ended December 31, 2016, and has reclassified the presentation of deferred income taxes in the prior period to conform with the current year classification in the consolidated balance sheets. As a result of the Company having recognized a valuation reserve for the entire deferred tax liability balance at March 31, 2017 and December 31, 2016, there is no impact of the presentation of deferred income taxes in our financial statements.   In January 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. The update intends to enhance the reporting model for financial instruments to provide users of financial statements with more decision-useful information and addresses certain aspects of the recognition, measurement, presentation, and disclosure of financial instruments. The new standard affects all entities that hold financial assets or owe financial liabilities. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Management is evaluating the impact of the adoption of these changes will have on the consolidated financial statements.

Reclassifications   Certain reclassifications have been made to the 2016 financial statements in order for them to conform to the 2017 presentation. Such reclassifications have no impact on the Company’s financial position or results of operations.

50000

0.08

3000000 These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company's common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol "SCIE". Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities."

EX-101.SCH 7 scie-20170331.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Nature of Business and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Liabilities link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Shareholders’ Deficit link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Contingencies link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Shareholders’ Deficit (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Liabilities (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Liabilities - Schedule of Balance of Debentures (Details) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Shareholders' Deficit (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Fair Value Measurements (Details Narartive) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Contingencies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Subsequent Events (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 8 scie-20170331_cal.xml XBRL CALCULATION FILE EX-101.DEF 9 scie-20170331_def.xml XBRL DEFINITION FILE EX-101.LAB 10 scie-20170331_lab.xml XBRL LABEL FILE Equity Components [Axis] Series B Preferred Stock [Member] Series C Preferred Stock [Member] Series A Preferred Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Accumulated Deficit [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Engagement Agreement [Member] Related Party [Axis] Oncoscope, Inc [Member] Antidilutive Securities [Axis] Preferred Stock [Member] Warrant [Member] Short-term Debt, Type [Axis] Unsecured Note Payable [Member] Long-Term Debt, Type [Axis] 10% promissory notes [Member] Two Affiliates [Member] ConvertibleDebenturesMember Range [Axis] Minimum [Member] Maximum [Member] Variable Debentures [Member] Derivative Financial Instruments, Liabilities [Member] Fair Value By Liability Class [Axis] Conversion Feature [Member] Commitment In Excess of Authorized Stock [Member] Series AA Super Voting Preferred Stock [Member] Award Type [Axis] Fair Value, Hierarchy [Axis] Fair Value, Inputs, Level 3 [Member] Warrant liability [Member] Series AA Super Voting Preferred [Member] Convertible Debentures [Member] Measurement Frequency [Axis] Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Plan Name [Axis] Equity Incentive Plan 2011 [Member] Convertible Debentures [Member] Options [Member] Third Party [Member] Secured Convertible Debenture [Member] Holder [Member] Derivative Instrument [Axis] Warrants [Member] Consultant [Member] Legal Entity [Axis] Oakmore Opportunity Fund I LP [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Variable Rate Convertible Debentures [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Accounts receivable, net Inventory Prepaid expenses and other current assets Total current assets Patents, net Total assets LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities: Accounts payable Accrued expenses Notes payable- related parties Note payable Convertible debt, net of discounts of $325,848 as of March 31, 2017 and $203,444 as of December 31, 2016 Derivative liability Total current liabilities Long-term secured convertible debt COMMITMENTS AND CONTINGENCIES Mezzanine equity Convertible Preferred Stock Total mezzanine equity Shareholders' deficit Convertible Preferred Stock, value Common stock, $.01 par value; 1,996,000,000 shares authorized; 1,413,320,059 and 883,671,222 shares issued and outstanding as of March 31, 2017 and December 31, 2016 Additional paid in capital Accumulated deficit Total shareholders' deficit Total liabilities and shareholders' deficit Discounts on convertible debt Preferred stock, par value Preferred stock, authorized Preferred stock, issued Preferred stock, outstanding Preferred stock, liquidation value Preferred stock, accumulated and unpaid dividends Common stock, par value Common stock, authorized Common stock, issued Common stock, outstanding Income Statement [Abstract] Operating expenses: Research and development General and administrative Sales and marketing Loss from operations Other income (expense) Interest expense Change in fair value of derivative and warrant liabilities Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Loss on issuance of variable rate debt Gain on extinguishment of debt Loss on foreign exchange transactions Other income (expense), net Net loss Basic and diluted loss per share Weighted average common shares outstanding: Basic and diluted Basic and diluted loss per share Weighted average common shares outstanding: Basic and diluted Balance, beginning Balance, beginning, shares Non cash issuance of stock options Conversion of convertible debt Conversion of convertible debt, shares Non cash issuance of warrant for consulting services Net loss Balance, ending Balance, ending, shares Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to cash used in operating activities: Amortization and depreciation Non-cash interest from forbearance on and issuance of variable rate convertible debentures Non-cash issuance of stock options and warrants Non-cash (income) expense related to commitment of common stock in excess of authorized shares Amortization of derivative and warrant liabilities discount Amortization of deferred debt issuance costs and original issue discount Issuance of debt and common stock for services Change in fair value of derivative and warrant liabilities Gain on extinguishment of debt Changes in assets and liabilities: Accounts receivable Inventory Prepaid expense and other assets Accounts payable Accrued expenses Net cash used in operating activities Investing activities: Net cash used in investing activities Financing activities: Proceeds from issuance of convertible notes payable Proceeds from issuance of notes payable to related parties Payments on convertible notes payable Debt issuance costs Net cash provided by financing activities Net decrease in cash Cash, beginning of year Cash, end of period Supplemental Disclosure of Cash Flow Information: Cash paid during the period for: Interest Income taxes Non Cash Investing and Financing Activities: Conversion of convertible notes and accrued interest to common stock Conversion of interest payable to increase in note Conversion of note payable to convertible note payable Organization, Consolidation and Presentation of Financial Statements [Abstract] Nature of Business and Basis of Presentation Accounting Policies [Abstract] Summary of Significant Accounting Policies Debt Disclosure [Abstract] Liabilities Equity [Abstract] Shareholders' Deficit Fair Value Disclosures [Abstract] Fair Value Measurements Commitments and Contingencies Disclosure [Abstract] Contingencies Subsequent Events [Abstract] Subsequent Events Revenue recognition Consolidation Risks and Uncertainties Use of Estimates Inventory Valuation Valuation of Long-lived Assets EX-101.PRE 11 scie-20170331_pre.xml XBRL PRESENTATION FILE XML 12 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	May 12, 2017
Document And Entity Information
Entity Registrant Name	SPECTRASCIENCE INC
Entity Central Index Key	0000727672
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		1,440,320,059
Trading Symbol	SCIE
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2017

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash	$ 100,001	$ 3,550
Accounts receivable, net		950
Inventory	97,423	90,594
Prepaid expenses and other current assets	225,621	266,749
Total current assets	423,045	361,843
Patents, net	984,687	1,024,524
Total assets	1,407,732	1,386,367
Current liabilities:
Accounts payable	1,499,584	1,318,737
Accrued expenses	2,458,162	2,278,042
Notes payable- related parties	35,000	35,000
Note payable	112,982	137,982
Convertible debt, net of discounts of $325,848 as of March 31, 2017 and $203,444 as of December 31, 2016	6,131,274	6,211,861
Derivative liability	833,082	819,928
Total current liabilities	11,070,084	10,801,550
Long-term secured convertible debt	1,350,000	1,100,000
Total mezzanine equity	30,850	30,850
Shareholders' deficit
Common stock, $.01 par value; 1,996,000,000 shares authorized; 1,413,320,059 and 883,671,222 shares issued and outstanding as of March 31, 2017 and December 31, 2016	14,133,200	8,836,712
Additional paid in capital	29,792,890	34,582,771
Accumulated deficit	(54,969,295)	(53,965,519)
Total shareholders' deficit	(11,043,202)	(10,546,033)
Total liabilities and shareholders' deficit	1,407,732	1,386,367
Series B Preferred Stock [Member]
Current liabilities:
Convertible Preferred Stock	25,850	25,850
Series C Preferred Stock [Member]
Current liabilities:
Convertible Preferred Stock	5,000	5,000
Series A Preferred Stock [Member]
Shareholders' deficit
Convertible Preferred Stock, value
Series AA Super Voting Preferred Stock [Member]
Shareholders' deficit
Convertible Preferred Stock, value	$ 3	$ 3

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Discounts on convertible debt	$ 325,848	$ 203,444
Common stock, par value	$ 0.01	$ 0.01
Common stock, authorized	1,996,000,000	1,996,000,000
Common stock, issued	1,413,320,059	883,671,222
Common stock, outstanding	1,413,320,059	883,671,222
Series B Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	2,585,000	2,585,000
Preferred stock, issued	2,585,000	2,585,000
Preferred stock, outstanding	2,585,000	2,585,000
Preferred stock, liquidation value	$ 517,000	$ 517,000
Preferred stock, accumulated and unpaid dividends	$ 106,931	$ 106,931
Series C Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	500,000	500,000
Preferred stock, issued	500,000	500,000
Preferred stock, outstanding	500,000	500,000
Preferred stock, liquidation value	$ 100,000	$ 100,000
Series A Preferred Stock [Member]
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized	0	0
Preferred stock, issued	0	0
Preferred stock, outstanding	0	0
Series AA Super Voting Preferred Stock [Member]
Preferred stock, par value	$ 0.001	$ .001
Preferred stock, authorized	3,000	0
Preferred stock, issued	3,000	0
Preferred stock, outstanding	3,000	0

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operation (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating expenses:
Research and development	$ 130,842	$ 194,007
General and administrative	279,732	307,841
Sales and marketing	74,854	79,413
Loss from operations	485,428	581,261
Other income (expense)	(485,428)	(581,261)
Interest expense
Change in fair value of derivative and warrant liabilities	(184,709)	(374,130)
Amortization of derivative and warrant liabilities discount	167,787	(887,494)
Amortization of deferred debt issuance costs and original issue discount	(130,408)	(141,561)
Loss on issuance of variable rate debt	(6,734)	(62,530)
Gain on extinguishment of debt	(368,743)
Loss on foreign exchange transactions	10,551	1,166
Other income (expense), net	(6,092)	(8,924)
Net loss		(1,600)
Basic and diluted loss per share	(518,348)	(1,475,073)
Weighted average common shares outstanding: Basic and diluted	$ (1,003,776)	$ (2,056,334)
Basic and diluted loss per share	$ (0.00)	$ (0.00)
Weighted average common shares outstanding: Basic and diluted	1,090,120,075	609,825,530

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statement of Shareholders' Deficit (unaudited) - 3 months ended Mar. 31, 2017 - USD ($)	Series AA Super Voting Preferred [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Total
Balance, beginning at Dec. 31, 2016	$ 3	$ 8,836,712	$ 34,582,771	$ (53,965,519)	$ (10,546,033)
Balance, beginning, shares at Dec. 31, 2016	3,000	883,671,222
Non cash issuance of stock options			40,001		40,001
Conversion of convertible debt		$ 5,296,488	(4,830,174)		466,314
Conversion of convertible debt, shares		529,648,837
Non cash issuance of warrant for consulting services			292		292
Net loss				(1,003,776)	(1,003,776)
Balance, ending at Mar. 31, 2017	$ 3	$ 14,133,200	$ 29,792,890	$ (54,969,295)	$ (11,043,202)
Balance, ending, shares at Mar. 31, 2017	3,000	1,413,320,059

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating activities:
Net loss	$ (1,003,776)	$ (2,056,334)
Adjustments to reconcile net loss to cash used in operating activities:
Amortization and depreciation	39,837	40,552
Non-cash interest from forbearance on and issuance of variable rate convertible debentures	385,102	94,329
Non-cash issuance of stock options and warrants	40,001	40,001
Non-cash (income) expense related to commitment of common stock in excess of authorized shares	(38,902)	131,504
Amortization of derivative and warrant liabilities discount	130,408	141,561
Amortization of deferred debt issuance costs and original issue discount	6,734	62,530
Issuance of debt and common stock for services	11,000	350
Change in fair value of derivative and warrant liabilities	(167,787)	887,494
Gain on extinguishment of debt	(10,551)	(1,166)
Changes in assets and liabilities:
Accounts receivable	950	7,061
Inventory	(6,829)	(31,639)
Prepaid expense and other assets	41,128	36,887
Accounts payable	180,844	127,720
Accrued expenses	199,961	112,154
Net cash used in operating activities	(191,880)	(406,996)
Investing activities:
Net cash used in investing activities
Financing activities:
Proceeds from issuance of convertible notes payable	309,000	300,000
Proceeds from issuance of notes payable to related parties		35,000
Payments on convertible notes payable	(669)
Debt issuance costs	(20,000)	(53,712)
Net cash provided by financing activities	288,331	281,288
Net decrease in cash	96,451	(125,708)
Cash, beginning of year	3,550	127,493
Cash, end of period	100,001	1,785
Cash paid during the period for:
Interest	1,000
Income taxes
Non Cash Investing and Financing Activities:
Conversion of convertible notes and accrued interest to common stock	88,419	75,812
Conversion of interest payable to increase in note	13,767
Conversion of note payable to convertible note payable	$ 25,000

XML 18 R7.htm IDEA: XBRL DOCUMENT

Nature of Business and Basis of Presentation

3 Months Ended

Mar. 31, 2017

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Nature of Business and Basis of Presentation

1. Nature of Business and Basis of Presentation

Description of Business

Basis of Presentation

Going Concern

XML 19 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Revenue recognition

Consolidation

Risks and Uncertainties

Use of Estimates

Inventory Valuation

Valuation of Long-lived Assets

Variable Conversion Rate Debentures

Over Commitment of Shares

Stock-Based Compensation

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

Earnings (Loss) Per Share

For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	March 31, 2017		March 31, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		1,604,110,127		378,651,041
Options		34,168,800		34,168,800
Warrants		111,200,650		132,875,170
Total		1,752,564,577		548,780,011

The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:

	Three Months Ended
	March 31,
	2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,003,776	)	$	(2,056,334	)
Net loss for diluted earnings per share	$	(1,003,776	)	$	(2,056,334	)

Denominator:
Weighted average basic shares outstanding		1,090,120,075			609,825,530
Denominator for diluted earnings per share-Adjusted weighted average shares		1,090,120,075			609,825,530

Income (loss) per share
Basic	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)

Inventory

Inventory consisted of the following at March 31, 2017 and December 31, 2016:

	March 31, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

Recently Adopted and Issued Accounting Pronouncements

Reclassifications

XML 20 R9.htm IDEA: XBRL DOCUMENT

Liabilities

3 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Liabilities

3. Liabilities

Note Payable

Notes Payable- Related Parties

Convertible Debentures

As of March 31, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:

	March 31, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		60,000			320,000
Issuance of debentures for services		10,000			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(82,345	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,457,122			6,415,305
Less unamortized costs of financing		325,848			203,444
Convertible debt, net of unamortized costs	$	6,131,274		$	6,211,861

Convertible debt in default	$	5,998,875		$	5,991,570

Secured Convertible Note

Derivative Liability

As of March 31, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

							Commitment
							In Excess of
				Conversion			Authorized
	Warrants			Feature			Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352
Change in fair value at year end		(55,329	)		(112,458	)		-			(167,787	)
Elimination of liability on conversion		-			(410,509	)		-			(410,509	)
Over commitment of stock		-			-			(38,902	)		(38,902	)
Balance at March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

Debentures with warrants attached issued subsequent to March 31, 2013 did not contain an exchange provision and were accounted for using the equity method of valuing the note and warrant.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Shareholders’ Deficit

3 Months Ended

Mar. 31, 2017

Equity [Abstract]

Shareholders' Deficit

4. Shareholders’ Deficit

Common Stock

Warrants

The balance of all warrants outstanding as of March 31, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		5,500,000		$	0.0200	$	0.0006
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at March 31, 2017		111,200,650		$	0.0742

Exercisable at March 31, 2017		111,200,650		$	0.0742

Stock Options

Options outstanding as of March 31, 2017 are as follows:

			Weighted		Weighted Average
			Average		Remaining		Aggregate
			Exercise Price		Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at March 31, 2017		34,168,800	$	0.02		6.79	$	-

Exercisable at March 31, 2017		26,725,761	$	0.02		6.79	$	-

Weighted average fair value of options granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company’s common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

Series AA Preferred Shares

XML 22 R11.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2017

Fair Value Disclosures [Abstract]

Fair Value Measurements

5. Fair Value Measurements

Accounting guidance on fair value measurements and disclosures defines fair value, establishes a framework for measuring the fair value of assets and liabilities using a hierarchy system, and defines

Level 1: uses quoted market prices in active markets for identical assets or liabilities.

Level 2: uses observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: uses unobservable inputs that are not corroborated by market data.

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of March 31, 2017:

	Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of March 31, 2017
Derivative liability	$	-	$	-	$	783,579	$	783,579
Warrant liability		-		-		29,949		29,949
Commitment in excess of authorized stock		-		-		19,554		19,554
Total	$	-	$	-	$	833,082	$	833,082

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended March 31, 2017:

							Commitment
							In Excess of
	Warrant			Derivative			Authorized			Total
	Liability			Liability			Stock			Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352

Elimination of liability on conversion		-			(410,509	)		-			(410,509	)

Change in estimated fair value (1)		(55,329	)		(112,458	)		-			(167,787	)

Change in commitment in excess of authorized stock		-			-			(38,902	)		(38,902	)

Balance March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Management used the following inputs to value the Derivative and Warrant Liabilities for the three months ended March 31, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 249%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.06%	1.93%
Forfeitures	None	None

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 23 R12.htm IDEA: XBRL DOCUMENT

Contingencies

3 Months Ended

Mar. 31, 2017

Commitments and Contingencies Disclosure [Abstract]

Contingencies

6. Contingencies

Legal Proceedings

XML 24 R13.htm IDEA: XBRL DOCUMENT

Subsequent Events

3 Months Ended

Mar. 31, 2017

Subsequent Events [Abstract]

Subsequent Events

7. Subsequent Events

Secured Convertible Debentures

Variable Rate Convertible Debentures

Increase in Authorized Shares

Subsequent events have been evaluated through the date financial statements are filed with the Securities and Exchange Commission.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Revenue recognition

Revenue recognition

Consolidation

Consolidation

Risks and Uncertainties

Risks and Uncertainties

Use of Estimates

Use of Estimates

Inventory Valuation

Inventory Valuation

Valuation of Long-lived Assets

Valuation of Long-lived Assets

Variable Conversion Rate Debentures

Variable Conversion Rate Debentures

Over Commitment of Shares

Over Commitment of Shares

Stock-based Compensation

Stock-Based Compensation

granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.

Earnings (loss) Per Share

Earnings (Loss) Per Share

For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	March 31, 2017		March 31, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		1,604,110,127		378,651,041
Options		34,168,800		34,168,800
Warrants		111,200,650		132,875,170
Total		1,752,564,577		548,780,011

The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:

	Three Months Ended
	March 31,
	2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,003,776	)	$	(2,056,334	)
Net loss for diluted earnings per share	$	(1,003,776	)	$	(2,056,334	)

Denominator:
Weighted average basic shares outstanding		1,090,120,075			609,825,530
Denominator for diluted earnings per share-Adjusted weighted average shares		1,090,120,075			609,825,530

Income (loss) per share
Basic	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)

Inventory

Inventory

Inventory consisted of the following at March 31, 2017 and December 31, 2016:

	March 31, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

Recently Adopted and Issued Accounting Pronouncements

Recently Adopted and Issued Accounting Pronouncements

Reclassifications

Reclassifications

XML 26 R15.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2017

Accounting Policies [Abstract]

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the three month periods ended March 31, 2017 and 2016, the following common equivalent shares were excluded from the computation of loss per share since their effects are anti-dilutive.

	March 31, 2017		March 31, 2016

Preferred Stock		3,085,000		3,085,000
Convertible debentures		1,604,110,127		378,651,041
Options		34,168,800		34,168,800
Warrants		111,200,650		132,875,170
Total		1,752,564,577		548,780,011

Schedule of Earnings Per Share Basic and Diluted

The following table sets forth the computation of basic and diluted loss per share for the three month periods ended March 31, 2017 and 2016:

	Three Months Ended
	March 31,
	2017			2016

Numerator:
Net loss for basic earnings per share	$	(1,003,776	)	$	(2,056,334	)
Net loss for diluted earnings per share	$	(1,003,776	)	$	(2,056,334	)

Denominator:
Weighted average basic shares outstanding		1,090,120,075			609,825,530
Denominator for diluted earnings per share-Adjusted weighted average shares		1,090,120,075			609,825,530

Income (loss) per share
Basic	$	(0.00	)	$	(0.00	)
Diluted	$	(0.00	)	$	(0.00	)

Schedule of Inventory

Inventory consisted of the following at March 31, 2017 and December 31, 2016:

	March 31, 2017		December 31, 2016

Raw materials	$	256,163	$	256,163
Finished goods		37,697		30,868
		293,860		287,031
Reserve for obsolescence		-		-
		293,860		287,031
Less long-term portion		196,437		196,437
	$	97,423	$	90,594

XML 27 R16.htm IDEA: XBRL DOCUMENT

Liabilities (Tables)

3 Months Ended

Mar. 31, 2017

Debt Disclosure [Abstract]

Schedule of Balance of Debentures

As of March 31, 2017 and December 31, 2016, the balances of the Debentures and Variable Debentures are as follows:

	March 31, 2017			December 31, 2016

Balance at beginning of period	$	6,415,305		$	6,174,760
Issuance of debentures for cash		60,000			320,000
Issuance of debentures for services		10,000			15,000
Issuance of debentures for forbearance		16,064			65,282
Debentures repaid in cash		(669	)		-
Debentures converted to common stock		(82,345	)		(291,754	)
Debentures exchanged for new debentures		38,767			132,017
Convertible debt		6,457,122			6,415,305
Less unamortized costs of financing		325,848			203,444
Convertible debt, net of unamortized costs	$	6,131,274		$	6,211,861

Convertible debt in default	$	5,998,875		$	5,991,570

Schedule of Balances of Derivative Liability

As of March 31, 2017 and December 31, 2016, the balances of the Derivative Liability are as follows:

							Commitment
							In Excess of
				Conversion			Authorized
	Warrants			Feature			Stock			Total

Balance at January 1, 2016	$	60,420		$	495,473		$	64,428		$	620,321

Liability on issuance of debt and warrants		44,394			697,256			-			741,650
Change in fair value at year end		(22,378	)		718,458			-			696,080
Elimination of liability on conversion		-			(1,232,151	)		-			(1,232,151	)
Over commitment of stock		-			-			(5,972	)		(5,972	)
Balance at December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352
Change in fair value at year end		(55,329	)		(112,458	)		-			(167,787	)
Elimination of liability on conversion		-			(410,509	)		-			(410,509	)
Over commitment of stock		-			-			(38,902	)		(38,902	)
Balance at March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

XML 28 R17.htm IDEA: XBRL DOCUMENT

Shareholders’ Deficit (Tables)

3 Months Ended

Mar. 31, 2016

Equity [Abstract]

Schedule of Warrants Outstanding

The balance of all warrants outstanding as of March 31, 2017 is as follows:

				Weighted		Weighted
				Average		Average
				Exercise		Fair
	Warrants			Price		Value
Outstanding at January 1, 2017		132,278,221		$	0.0765
Granted		5,500,000		$	0.0200	$	0.0006
Cancelled		(26,577,571	)	$	0.0745
Exercised		-		$	-
Outstanding at March 31, 2017		111,200,650		$	0.0742

Exercisable at March 31, 2017		111,200,650		$	0.0742

Schedule of Stock Options Outstanding

Options outstanding as of March 31, 2017 are as follows:

			Weighted		Weighted Average
			Average		Remaining		Aggregate
			Exercise Price		Contractual		Intrinsic
	Options		Per Share		Term (years)		Value (1)
Outstanding at January 1, 2017		34,168,800	$	0.02		7.03
Granted		-	$	-		-
Cancelled		-	$	-		-
Exercised		-	$	-		-
Outstanding at March 31, 2017		34,168,800	$	0.02		6.79	$	-

Exercisable at March 31, 2017		26,725,761	$	0.02		6.79	$	-

Weighted average fair value of options granted during the period		-	$	-

(1)	These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company’s common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol “SCIE”.

XML 29 R18.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2016

Fair Value Disclosures [Abstract]

Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis

The following table presents the balances of derivative liabilities which are measured at fair value on a recurring basis by level as of March 31, 2017:

	Fair Value Measurements Using
	Quoted Prices in		Significant Other		Significant
	Active Markets for		Observable		Unobservable
	Identical Assets		Inputs		Inputs
	(Level 1)		(Level 2)		(Level 3)		Total

As of March 31, 2017
Derivative liability	$	-	$	-	$	783,579	$	783,579
Warrant liability		-		-		29,949		29,949
Commitment in excess of authorized stock		-		-		19,554		19,554
Total	$	-	$	-	$	833,082	$	833,082

Schedule Changes in Liabilities with Significant Unobservable Inputs

The following table presents changes in the derivative liabilities with significant unobservable inputs (Level 3) for the three months ended March 31, 2017:

							Commitment
							In Excess of
	Warrant			Derivative			Authorized			Total
	Liability			Liability			Stock			Liability
Balance December 31, 2016	$	82,436		$	679,036		$	58,456		$	819,928

Liability on issuance of debt and warrants		2,842			627,510			-			630,352

Elimination of liability on conversion		-			(410,509	)		-			(410,509	)

Change in estimated fair value (1)		(55,329	)		(112,458	)		-			(167,787	)

Change in commitment in excess of authorized stock		-			-			(38,902	)		(38,902	)

Balance March 31, 2017	$	29,949		$	783,579		$	19,554		$	833,082

(1) Included in the Condensed Statements of Operation on the line “Change in fair value of derivative and warrant liabilities.”

Schedule of Derivative and Warrant Liabilities

Management used the following inputs to value the Derivative and Warrant Liabilities for the three months ended March 31, 2017:

	Derivative Liability	Warrant Liability
Expected term	6 months to 2 years	5 years
Exercise price	$0.0001 - $0.074	$0.02 - $0.1287
Expected volatility	216% to 240%	242% to 249%
Expected dividends	None	None
Risk-free interest rate	0.79% to 1.06%	1.93%
Forfeitures	None	None

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References + Details

XML 30 R19.htm IDEA: XBRL DOCUMENT

Nature of Business and Basis of Presentation (Details Narrative)	3 Months Ended
	Mar. 31, 2017 USD ($) IndividualInvestors IntellectualProperty	Dec. 31, 2016 USD ($)	Mar. 31, 2016 USD ($)	Dec. 31, 2015 USD ($)
Number of U.S. patents \| IndividualInvestors	34
Number of additional patent issued \| IntellectualProperty	28
Working capital deficit	$ 10,647,039	$ 10,439,707
Cash	100,001	3,550	$ 1,785	$ 127,493
Convertible debentures face amount	5,998,875	$ 5,991,570
Convertible Debentures [Member]
Convertible debentures face amount	$ 5,998,875
Number of individual default \| IndividualInvestors	80
Engagement Agreement [Member]
Maximum capital raising	$ 289,000
Payments of transaction costs	$ 20,000

XML 31 R20.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Significant Accounting Policies [Line Items]
Options outstanding exercisable	34,168,800
Inventory raw materials	$ 256,163	$ 256,163
Inventory raw material sold		2,100
Oncoscope, Inc [Member]
Significant Accounting Policies [Line Items]
Inventory raw materials		$ 40,000
Equity Incentive Plan 2011 [Member]
Significant Accounting Policies [Line Items]
Number of shares reserved	40,000,000
Options outstanding exercisable	26,725,761

XML 32 R21.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Antidilutive securities excluded from computation of earnings per share, amount	1,752,564,577	548,780,011
Preferred Stock [Member]
Antidilutive securities excluded from computation of earnings per share, amount	3,085,000	3,085,000
Convertible Debentures [Member]
Antidilutive securities excluded from computation of earnings per share, amount	1,604,110,127	378,651,041
Options [Member]
Antidilutive securities excluded from computation of earnings per share, amount	34,168,800	34,168,800
Warrant [Member]
Antidilutive securities excluded from computation of earnings per share, amount	111,200,650	132,875,170

XML 33 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Accounting Policies [Abstract]
Net loss for basic earnings per share	$ (1,003,776)	$ (2,056,334)
Net loss for diluted earnings per share	$ (1,003,776)	$ (2,056,334)
Weighted average basic shares outstanding	1,090,120,075	609,825,530
Denominator for diluted earnings per share-adjusted weighted average shares	1,090,120,075	609,825,530
Basic	$ (0.00)	$ 0.00
Diluted	$ (0.00)	$ 0.00

XML 34 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Schedule of Inventory (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Accounting Policies [Abstract]
Raw materials	$ 256,163	$ 256,163
Finished goods	37,697	30,868
Inventory, gross	293,860	287,031
Reserve for obsolescence
Inventories current and non current	293,860	287,031
Less long-term portion	196,437	196,437
Inventories	$ 97,423	$ 90,594

XML 35 R24.htm IDEA: XBRL DOCUMENT

Liabilities (Details Narrative) - USD ($)			1 Months Ended	3 Months Ended
Liabilities (Details Narrative) - USD ($)	Oct. 02, 2015	Feb. 18, 2015	Nov. 30, 2014	Mar. 31, 2017	Mar. 31, 2016
Debt Instrument [Line Items]
Accrued interest rate				10.00%
Note payable				$ 112,982
Notes payable- related parties				35,000
Unsecured Note Payable [Member]
Debt Instrument [Line Items]
Debt instruments face amount			$ 100,000
Warrant term			5 years
Exercise price per share			$ 0.09
Repayment of debt		$ 115,000
Number of stock issued during period for debt offering costs			50,000
Remaining balance of notes payable	$ 137,982
Increased principal balance note payable			$ 137,982
Accrued interest rate	20.00%
Third Party [Member]
Debt Instrument [Line Items]
Note payable				25,000
Debentures outstanding				150,000
Accrued interest				13,767
10% promissory notes [Member] \| Two Affiliates [Member]
Debt Instrument [Line Items]
Notes payable- related parties					$ 35,000
ConvertibleDebenturesMember
Debt Instrument [Line Items]
Debt instruments face amount				$ 82,345
Warrant term				5 years
Debentures outstanding				$ 5,977,082
ConvertibleDebenturesMember \| Minimum [Member]
Debt Instrument [Line Items]
Exercise price per share				$ 0.0745
Accrued interest rate				10.00%
Percent original issue discount				5.00%
Conversion price per share				$ 0.01
Convertible debentures exercise price				0.0745
ConvertibleDebenturesMember \| Maximum [Member]
Debt Instrument [Line Items]
Exercise price per share				$ 0.1287
Accrued interest rate				20.00%
Percent original issue discount				10.00%
Conversion price per share				$ 0.099
Convertible debentures exercise price				$ 0.1287
Variable Debentures [Member]
Debt Instrument [Line Items]
Debentures outstanding				$ 480,040
Variable Debentures [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Accrued interest rate				0.00%
Percent original issue discount				0.00%
Variable issue discount rate				40.00%
Debt payment term				9 months
Debt subsequent issuance premiums				0.00%
Variable Debentures [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Accrued interest rate				10.00%
Percent original issue discount				10.00%
Variable issue discount rate				50.00%
Debt payment term				1 year
Debt subsequent issuance premiums				10.00%
Secured Convertible Debenture [Member]
Debt Instrument [Line Items]
Accrued interest rate				8.00%
Conversion price per share				$ 0.01
Debt payment term				3 years
Issued debenture for cash				$ 250,000
Secured Convertible Debenture [Member] \| Holder [Member]
Debt Instrument [Line Items]
Warrant term				5 years
Issued debenture for cash				$ 100,000
Warrant to purchase of common stock				5,000,000
Warrant exercise price				$ 0.02
Fair value of warrants				$ 292
Derivative Financial Instruments, Liabilities [Member]
Debt Instrument [Line Items]
Number of shares issued upon conversion				1,166,000,000

XML 36 R25.htm IDEA: XBRL DOCUMENT

Liabilities - Schedule of Balance of Debentures (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Debt Disclosure [Abstract]
Balance at beginning of period	$ 6,415,305	$ 6,174,760
Issuance of debentures for cash	60,000	320,000
Issuance of debentures for services	10,000	15,000
Issuance of debentures for forbearance	16,064	65,282
Debentures repaid in cash	(669)
Debentures converted to common stock	(82,345)	(291,754)
Debenture exchanged for new debentures	38,767	132,017
Convertible debt	6,457,122	6,415,305
Less unamortized costs of financing	325,848	203,444
Convertible debt, net of unamortized costs	6,131,274	6,211,861
Convertible debt in default	$ 5,998,875	$ 5,991,570

XML 37 R26.htm IDEA: XBRL DOCUMENT

Liabilities - Schedule of Balances of Derivative Liability (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Debt Instrument [Line Items]
Balance at beginning	$ 819,928	$ 620,321
Liability on issuance of debt and warrants	630,352	741,650
Change in fair value at year end	(167,787)	696,080
Elimination of liability on conversion	(410,509)	(1,232,151)
Over commitment of stock	(38,902)	(5,972)
Balance at ending	833,082	819,928
Warrant [Member]
Debt Instrument [Line Items]
Balance at beginning	82,436	60,420
Liability on issuance of debt and warrants	2,842	44,394
Change in fair value at year end	(55,329)	(22,378)
Elimination of liability on conversion
Over commitment of stock
Balance at ending	29,949	82,436
Conversion Feature [Member]
Debt Instrument [Line Items]
Balance at beginning	679,036	495,473
Liability on issuance of debt and warrants	627,510	697,256
Change in fair value at year end	(112,458)	718,458
Elimination of liability on conversion	(410,509)	(1,232,151)
Over commitment of stock
Balance at ending	783,579	679,036
Commitment In Excess of Authorized Stock [Member]
Debt Instrument [Line Items]
Balance at beginning	58,456	64,428
Liability on issuance of debt and warrants
Change in fair value at year end
Elimination of liability on conversion
Over commitment of stock	(38,902)	(5,972)
Balance at ending	$ 19,554	$ 58,456

XML 38 R27.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
Shareholders' Deficit (Details Narrative) - USD ($)	Mar. 31, 2017	Mar. 31, 2016	Dec. 31, 2016
Gain on extinguishment of debt	$ 10,551	$ 1,166
Total unrecognized estimated employee compensation cost	$ 133,323
Series AA Super Voting Preferred Stock [Member]
Preferred stock, authorized	3,000		0
Preferred stock, par value	$ 0.001		$ .001
Preferred stock voting rights	Each holder of outstanding shares of Series AA Super Voting Preferred Stock shall be entitled to one million (1,000,000) votes for each share of Series AA Super Voting Preferred Stock held on the record date for the determination of stockholders entitled to vote at each meeting of stockholders of the Company
Dividend preferred stock	$ 25,000		$ 25,000
Convertible Debentures [Member]
Debt instruments face amount	82,345
Accrued interest	$ 6,074
Warrant term	5 years
Convertible Debentures [Member] \| Common Stock [Member]
Number of common stock converted into shares of common stock	529,648,837
Gain on extinguishment of debt	$ 15,651
Warrants [Member]
Warrant term	5 years
Number of warrant issued	500,000
Non cash operating expenses	$ 292
Warrants [Member] \| Holder [Member]
Fair value of warrants	2,925
Warrants [Member] \| Consultant [Member]
Number of warrant issued		1,000,000
Fair value of warrants	$ 1,652
Warrants [Member] \| Convertible Debentures [Member]
Warrant term	5 years
Number of warrant issued	5,000,000
Warrants exercise price	$ 0.02

XML 39 R28.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit - Schedule of Warrants Outstanding (Details) - Warrant [Member]	3 Months Ended
	Mar. 31, 2017 $ / shares shares
Shares, Outstanding at beginning \| shares	132,278,221
Shares, Granted \| shares	5,500,000
Shares, Cancelled \| shares	(26,577,571)
Shares, Exercised \| shares
Shares, Outstanding at ending \| shares	111,200,650
Shares, Exercisable at ending \| shares	111,200,650
Weighted Average Exercise Price, Outstanding at beginning	$ 0.0765
Weighted Average Exercise Price, Granted	0.0200
Weighted Average Exercise Price, Cancelled	0.0745
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Outstanding at ending	0.0742
Weighted Average Exercise Price, Exercisable at ending	0.0742
Weighted Average Fair Value, Granted	$ 0.0006

XML 40 R29.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit - Schedule of Stock Options Outstanding (Details)

3 Months Ended

Mar. 31, 2017

USD ($)

$ / shares

Shares, Exercisable at ending

34,168,800

Equity Incentive Plan 2011 [Member]

Shares, Outstanding at beginning

34,168,800

Shares, Granted

Shares, Cancelled

Shares, Exercised

Shares, Outstanding at ending

34,168,800

Shares, Exercisable at ending

26,725,761

Weighted Average Exercise Price, Outstanding at beginning | $ / shares

$ 0.02

Weighted Average Exercise Price, Granted | $ / shares

Weighted Average Exercise Price, Cancelled | $ / shares

Weighted Average Exercise Price, Exercised | $ / shares

Weighted Average Exercise Price, Outstanding at ending | $ / shares

0.02

Weighted Average Exercise Price, Exercisable at ending | $ / shares

$ 0.02

Weighted Average Remaining Contractual Terms in Years, Outstanding at beginning

7 years 11 days

Weighted Average Remaining Contractual Terms in Years, Outstanding at ending

6 years 9 months 15 days

Weighted Average Remaining Contractual Terms in Years, Exercisable at ending

6 years 9 months 15 days

Aggregate Intrinsic Value Outstanding at ending | $

^[1]

Aggregate Intrinsic Value Exercisable at ending | $

^[1]

[1]	These amounts represent the excess, if any, between the exercise price and $0.0006, the closing market price of the Company's common stock on March 31, 2017 as quoted on the Pink Sheets under the symbol "SCIE".

XML 41 R30.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details Narartive)	3 Months Ended
Fair Value Measurements (Details Narartive)	Mar. 31, 2017
Fair Value Disclosures [Abstract]
Description of valuation of derivative and warrant liability	In computing the fair value of the derivative and warrant liability at March 31, 2017, management estimated a 60% probability of a down round financing event at a price of $0.025 and a 9% to 34% probability that existing note holders with exchange privileges would exchange their existing debentures and warrants for new debentures and warrants.

XML 42 R31.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Measurements, Recurring [Member]	Mar. 31, 2017 USD ($)
Total Liability	$ 833,082
Fair Value, Inputs, Level 1 [Member]
Total Liability
Fair Value, Inputs, Level 2 [Member]
Total Liability
Fair Value, Inputs, Level 3 [Member]
Total Liability	833,082
Derivative Financial Instruments, Liabilities [Member]
Total Liability	783,579
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Derivative Financial Instruments, Liabilities [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	783,579
Warrant liability [Member]
Total Liability	29,949
Warrant liability [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Warrant liability [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Warrant liability [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	29,949
Commitment In Excess of Authorized Stock [Member]
Total Liability	19,554
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 1 [Member]
Total Liability
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 2 [Member]
Total Liability
Commitment In Excess of Authorized Stock [Member] \| Fair Value, Inputs, Level 3 [Member]
Total Liability	$ 19,554

XML 43 R32.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) - USD ($)

3 Months Ended

12 Months Ended

Mar. 31, 2017

Dec. 31, 2016

Balance at beginning

$ 819,928

$ 620,321

Change in estimated fair value

167,787

(696,080)

Balance at ending

833,082

819,928

Fair Value, Inputs, Level 3 [Member]

Balance at beginning

819,928

Liability on issuance of debt and warrants

630,352

Elimination of liability on conversion

(410,509)

Change in estimated fair value

^[1]

(167,787)

Change in commitment in excess of authorized stock

(38,902)

Balance at ending

833,082

819,928

Warrant liability [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

82,436

Liability on issuance of debt and warrants

2,842

Elimination of liability on conversion

Change in estimated fair value

^[1]

(55,329)

Change in commitment in excess of authorized stock

Balance at ending

29,949

82,436

Derivative Financial Instruments, Liabilities [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

679,036

Liability on issuance of debt and warrants

627,510

Elimination of liability on conversion

(410,509)

Change in estimated fair value

^[1]

(112,458)

Change in commitment in excess of authorized stock

Balance at ending

783,579

679,036

Commitment In Excess of Authorized Stock [Member]

Balance at beginning

58,456

64,428

Change in estimated fair value

Balance at ending

19,554

58,456

Commitment In Excess of Authorized Stock [Member] | Fair Value, Inputs, Level 3 [Member]

Balance at beginning

58,456

Liability on issuance of debt and warrants

Elimination of liability on conversion

Change in estimated fair value

^[1]

Change in commitment in excess of authorized stock

(38,902)

Balance at ending

$ 19,554

$ 58,456

[1]	Included in the Condensed Statements of Operation on the line "Change in fair value of derivative and warrant liabilities."

XML 44 R33.htm IDEA: XBRL DOCUMENT

Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details)	3 Months Ended
	Mar. 31, 2017 $ / shares
Derivative Financial Instruments, Liabilities [Member]
Expected dividends	0.00%
Forfeitures	0.00%
Derivative Financial Instruments, Liabilities [Member] \| Minimum [Member]
Expected term	6 months
Exercise price	$ 0.0001
Expected volatility	216.00%
Risk-free interest rate	0.79%
Derivative Financial Instruments, Liabilities [Member] \| Maximum [Member]
Expected term	2 years
Exercise price	$ 0.074
Expected volatility	240.00%
Risk-free interest rate	1.06%
Warrant liability [Member]
Expected term	5 years
Expected dividends	0.00%
Risk-free interest rate	1.93%
Forfeitures	0.00%
Warrant liability [Member] \| Minimum [Member]
Exercise price	$ 0.02
Expected volatility	242.00%
Warrant liability [Member] \| Maximum [Member]
Exercise price	$ 0.1287
Expected volatility	249.00%

XML 45 R34.htm IDEA: XBRL DOCUMENT

Contingencies (Details Narrative) - Oakmore Opportunity Fund I LP [Member] - USD ($)	Oct. 19, 2016	Jul. 07, 2016
Preliminary judgement amount		$ 116,500
Convertible note payable		22,500
Judgement amount	$ 521,100
Litigation cost		$ 150,000

XML 46 R35.htm IDEA: XBRL DOCUMENT

Subsequent Events (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended
Subsequent Events (Details Narrative) - USD ($)	May 31, 2017	Apr. 30, 2017	Mar. 31, 2017	Apr. 24, 2017	Dec. 31, 2016
Increase in authorized capital stock			1,996,000,000		1,996,000,000
Minimum [Member] \| Subsequent Event [Member]
Increase in authorized capital stock				2,000,000,000
Maximum [Member] \| Subsequent Event [Member]
Increase in authorized capital stock				3,000,000,000
Secured Convertible Debenture [Member]
Debt maturity term			3 years
Debt conversion price per share			$ 0.01
Secured Convertible Debenture [Member] \| Subsequent Event [Member]
Debt instruments face amount	$ 60,000
Cash consideration	$ 50,000
Debt maturity term	3 years
Debt conversion price per share	$ 0.01
Debt annual interest rate	8.00%
Warrant term	5 years
Number of warrant to purchase of common stock	3,000,000
Warrant exercise price	$ 0.02
Variable Rate Convertible Debentures [Member] \| Subsequent Event [Member]
Debt instruments face amount		$ 4,116
Accrued interest		$ 3,309
Number of common shares issued		27,000,000
Repayment of debt	$ 75,000
Variable Rate Convertible Debentures [Member] \| Minimum [Member] \| Subsequent Event [Member]
Debt subsequent issuance premiums	20.00%
Variable Rate Convertible Debentures [Member] \| Maximum [Member] \| Subsequent Event [Member]
Debt subsequent issuance premiums	35.00%

EXCEL 47 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 49 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 51 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 141 232 1 true 43 0 false 6 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://spectrascience.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets Sheet http://spectrascience.com/role/BalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://spectrascience.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operation (Unaudited) Sheet http://spectrascience.com/role/StatementsOfOperation Condensed Consolidated Statements of Operation (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Sheet http://spectrascience.com/role/StatementOfShareholdersDeficit Condensed Consolidated Statement of Shareholders' Deficit (unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://spectrascience.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Nature of Business and Basis of Presentation Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation Nature of Business and Basis of Presentation Notes 7 false false R8.htm 00000008 - Disclosure - Summary of Significant Accounting Policies Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 00000009 - Disclosure - Liabilities Sheet http://spectrascience.com/role/Liabilities Liabilities Notes 9 false false R10.htm 00000010 - Disclosure - Shareholders??? Deficit Sheet http://spectrascience.com/role/ShareholdersDeficit Shareholders??? Deficit Notes 10 false false R11.htm 00000011 - Disclosure - Fair Value Measurements Sheet http://spectrascience.com/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 00000012 - Disclosure - Contingencies Sheet http://spectrascience.com/role/Contingencies Contingencies Notes 12 false false R13.htm 00000013 - Disclosure - Subsequent Events Sheet http://spectrascience.com/role/SubsequentEvents Subsequent Events Notes 13 false false R14.htm 00000014 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 14 false false R15.htm 00000015 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies 15 false false R16.htm 00000016 - Disclosure - Liabilities (Tables) Sheet http://spectrascience.com/role/LiabilitiesTables Liabilities (Tables) Tables http://spectrascience.com/role/Liabilities 16 false false R17.htm 00000017 - Disclosure - Shareholders??? Deficit (Tables) Sheet http://spectrascience.com/role/ShareholdersDeficitTables Shareholders??? Deficit (Tables) Tables http://spectrascience.com/role/ShareholdersDeficit 17 false false R18.htm 00000018 - Disclosure - Fair Value Measurements (Tables) Sheet http://spectrascience.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://spectrascience.com/role/FairValueMeasurements 18 false false R19.htm 00000019 - Disclosure - Nature of Business and Basis of Presentation (Details Narrative) Sheet http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentationDetailsNarrative Nature of Business and Basis of Presentation (Details Narrative) Details http://spectrascience.com/role/NatureOfBusinessAndBasisOfPresentation 19 false false R20.htm 00000020 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://spectrascience.com/role/SummaryOfSignificantAccountingPoliciesTables 20 false false R21.htm 00000021 - Disclosure - Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 21 false false R22.htm 00000022 - Disclosure - Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfEarningsPerShareBasicAndDilutedDetails Summary of Significant Accounting Policies - Schedule of Earnings Per Share Basic and Diluted (Details) Details 22 false false R23.htm 00000023 - Disclosure - Summary of Significant Accounting Policies - Schedule of Inventory (Details) Sheet http://spectrascience.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfInventoryDetails Summary of Significant Accounting Policies - Schedule of Inventory (Details) Details 23 false false R24.htm 00000024 - Disclosure - Liabilities (Details Narrative) Sheet http://spectrascience.com/role/LiabilitiesDetailsNarrative Liabilities (Details Narrative) Details http://spectrascience.com/role/LiabilitiesTables 24 false false R25.htm 00000025 - Disclosure - Liabilities - Schedule of Balance of Debentures (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalanceOfDebenturesDetails Liabilities - Schedule of Balance of Debentures (Details) Details 25 false false R26.htm 00000026 - Disclosure - Liabilities - Schedule of Balances of Derivative Liability (Details) Sheet http://spectrascience.com/role/Liabilities-ScheduleOfBalancesOfDerivativeLiabilityDetails Liabilities - Schedule of Balances of Derivative Liability (Details) Details 26 false false R27.htm 00000027 - Disclosure - Shareholders' Deficit (Details Narrative) Sheet http://spectrascience.com/role/ShareholdersDeficitDetailsNarrative Shareholders' Deficit (Details Narrative) Details 27 false false R28.htm 00000028 - Disclosure - Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfWarrantsOutstandingDetails Shareholders' Deficit - Schedule of Warrants Outstanding (Details) Details 28 false false R29.htm 00000029 - Disclosure - Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Sheet http://spectrascience.com/role/ShareholdersDeficit-ScheduleOfStockOptionsOutstandingDetails Shareholders' Deficit - Schedule of Stock Options Outstanding (Details) Details 29 false false R30.htm 00000030 - Disclosure - Fair Value Measurements (Details Narartive) Sheet http://spectrascience.com/role/FairValueMeasurementsDetailsNarartive Fair Value Measurements (Details Narartive) Details http://spectrascience.com/role/FairValueMeasurementsTables 30 false false R31.htm 00000031 - Disclosure - Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfBalancesOfLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Balances of Liabilities Measured at Fair Value on Recurring Basis (Details) Details 31 false false R32.htm 00000032 - Disclosure - Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleChangesInLiabilitiesWithSignificantUnobservableInputsDetails Fair Value Measurements - Schedule Changes in Liabilities with Significant Unobservable Inputs (Details) Details 32 false false R33.htm 00000033 - Disclosure - Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Sheet http://spectrascience.com/role/FairValueMeasurements-ScheduleOfDerivativeAndWarrantLiabilitiesDetails Fair Value Measurements - Schedule of Derivative and Warrant Liabilities (Details) Details 33 false false R34.htm 00000034 - Disclosure - Contingencies (Details Narrative) Sheet http://spectrascience.com/role/ContingenciesDetailsNarrative Contingencies (Details Narrative) Details http://spectrascience.com/role/Contingencies 34 false false R35.htm 00000035 - Disclosure - Subsequent Events (Details Narrative) Sheet http://spectrascience.com/role/SubsequentEventsDetailsNarrative Subsequent Events (Details Narrative) Details http://spectrascience.com/role/SubsequentEvents 35 false false All Reports Book All Reports scie-20170331.xml scie-20170331.xsd scie-20170331_cal.xml scie-20170331_def.xml scie-20170331_lab.xml scie-20170331_pre.xml true true ZIP 53 0001493152-17-005734-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-17-005734-xbrl.zip M4$L#!!0 ( %9\MDI_^NA!1;D "R@"0 1 GWZ>G^X?]^'?O:$XMB+PQ^ M?&5>&*\T%@Q#UPL>?GSU^UWK\N[JYN:5]G]_^N__TN!_/_R?5DO[X#'??:.] M#X>MFV 4OM4^.F/V1ON9!2QRDC!ZJ_W=\:?X3?C!\UFD787CB<\2!C_PF=YH MG0NS/]1:K1+C_IT%;AC]_ODF'?[" M:31DZ5BPOFO-,LR>T6Z;FFG\3?N;J;W_\/'BZP@6\MY)X!G\^5OKO6'#ORSK MBVF^L:PWIOG_E9PP<9)IG$YH?.T;Q@?#,-K\]1^^WD>^]P;_K<%F!/&;K['W MXRMEC<_MBS!Z>&T9AOGZ__WVZ]WPD8V=EA?$B1,,V2OYEN\%?Q2]9PX&@]?T MJWQT[DF<7,[1?HT_WSMQ-C("N.3Y.4C@5S=)7U ?ME_S'W./>H6/=OFCGGS4 M93//Q6QX\1 ^O88?X'FSTS+,5MN4CT=LM!#D[FOX53[HQ6'',GO+UL>?D"], MX]:#XTS2%T9.?$\/BQ\0F%X>&/@E"GT6%[Y#OQ2\%(1!,!T7P^4FT>OD9<)> MPT,M>(I%WC!];_5+^1< !ORZ&#KZI0 Z+WAB<5*\(_PW?*F=?PF9+7TEGK!A M$CGQT .)PX!_QZ\E'[Z2;(6D^"8F@O_,1AI1\9M'VEM\KR5?N/@:NZ_$SP@Q M_.RAS'FEO99#<38;AD'"OB::Y_[XZD,4CN7"##,)^>=V*YL_?8T%B9>\I-^F MWWLN_C+R0,@1E"R'>8F/JYN_OOH).-[H6;UNS_KA]>S+V72O"^<3LTU@UT)W M'@I@ORA!4?53MAPY4O;;W&L@5Y67<-W9]&[N%?E]#@#YI4#I8CQ?QI]&? Z[ M95HUPRT7;LE/V0+2*<0O.T52%R:H'P$J2!(+V"N2ZLFE>4IJ[QM)8B/^);32 MO^Y@,!:_NP7AR:*(N7=)./SC-S:^9]'1$)E),/8P9@H&TI]< .;KQ/>&7L)A MU5P/GN3FJEC:&[2P&+Y__><4X$9S,PS@S_CRJQ>_^BE];#$&?GA=.)D*Z.MB M2.O$, TM5)P6CB<7KLZ>%@HQ<)9RH:&%JM'"\>3"Y=G30B$&SE(N-+10-5HX MAEP #(W#X/PH8&[=)RX#5NZ[;9EVS^AUVV=" )>NZR7PHN/?.IY[$UPY$R]Q M_(88#E][_^FKBGH4J^O$S8I]%E%#F!P '1"AY[O%F( MF$/32CU."Z3$$53S*1B&\3"!JT\IGY@#3W%A#^\@4()G:&J%WB=R_J M+PH!S:/@#*6,5$"GZ(I$T G.#Q==?A_[492XB!27F%/02 MO/9I)#7.+8ON'IV(O7LI'B"OKZK@P51< @GRZRKDUVW([T3)K[L)^76/3'[_ M<-#$2!JZ*TUW.8PU!%=D<75:IMEJ&RF1?0P3%M\Z+\Z]SSXECRP2G^/3(+N[ MQS!*OK!H_)[=)VBXYPEFQ>J/:'J)?=JKZ45S".'3T$6%Z2(G6L2NK2=:9LAI M3\Y<+D9P"T3FQ7$8O1 V\_&!+\_AY6CD^9Z3G I)_1H&#\D<19%35XB*U42T M5T>S8 >.ZFGN_XQC)H9U%09/+$H\8&O8,H!\&J54*J7@;U[@C:?CDR?0);C8 M,9EBS"PO:W,X/O%CMDU(T/G:D."^25#%\:F2X.JH?B,1*T*.QY2(]0C;;4O% MC5 ];:%ZRE35E%R.J$HBHR&SDHG&-:NL5/'\VD(\Y^]3YA1J MM].WK6Z_?^*\6SUC8D/2R=V$.ACI-,9$%8V)>I)08TS4S)BH'IDM*!30>,?' MB^4>HC"$W>QW9?;;/N!^-]9'1:R/8^]_8SI4WW0X,(TT'DIU9<0ABT4U,J*> M,N((-"+**U[>36'4OX>)%SR<8HF-%37%B$)*HN),Z*/0K[ MJS_H6I9==WJX M?'8B=_[,OBH.Q3$V.A6B-\%DFL2_LB?FM_,)O@(]J8P]#=F@:(_TXR\PCQ,- M'U\(#7DB68*HU22S:[56O"4-Z::D>Z:Y274EZIID3U67X!O"78-PSX4HSMDC MK)7X:US5Q7U1J[J(1LDE*"/AC0R+)RJU%B=O-E(D*I+D(HG;B[HTI._ M191DI5!/A)Z6%V9'1&!Z5 M#CSLFF[/R)ZH+-V>;R6TQE!H#(5J4^ 9R<>S];>.K+O3;?F-.?$THL.[^#,> MI$1>\#!#D$6Y*K.E(\\WVU'!X(>(_3EEP?!E0:[/$F3O+>EGXVRDO=3#/+ED MS%HRK]4P[XDSK]4P[ZDR;W//X-29M[D&<;+,*\WFA!%!5Z;TAW[7)]^QH9)U3X49N5DYNUN^@N!'HASD[;ICU=)CU:,?)#;,> MYH2Y8=;38=:F6FI%F%7P%J_]=Q,,$>@G=NL[ 3QT(F?+N)J/SI@I9+!TO:>Z M]:OK<#1D<$0RJ'@!C.T*IIX&"=6SI&[%"6O]^MT-,56B/O.QE)7T&="6"X,3 M,OQ74(1\;&[=C4 I5W>Y(9=S%QF7KNLE@$3'OW4\]R:XXOAG10]+<="( MDC*BI"&CBI%1A43,9Y8X7L#<:R<*P%P[D42WDD11O/A&J)01*@WA')UP#MZ2 MB.8XVA9OC:3N 61M5Y&UHB-0S1"6$T?=3<313">DO8@CNY:X58C1/E*[*"F_ M<^V@+;/=[5I6I^E]G4/^.>OW',H:LM@]653("9B5!8.V80ZLVF\ZC.MZ_A3/ MRK+&7==?A_[492ZB!?'?'GT(O<6@#N1.\:?F0\HXROZ M @Y [ R))-Z]J+\H)#.+@#/T-AM2J 8IU$-;+$CF M>I*+%+L5:V^HJ52Z9D-!E:&@ZJBF7T+?95'^'E=#*EN1REXUJ;I?C=S;A=PK MXH2&P,^2P(]\'S=WL-(QK5Z_US?[=:?%DB7.SN)@LEA$<5Y$K'U@SNEHV7*W M?0N7?F[[?W[WYIO[WVN%KBEQJLS-NQ.BEFVOWU7E_E5E$PIGR*JY6UZ-$@/= M?:9)+K- BI-2S/:@V^O;W;I3P!*?J$*'^!6(#&77,56L)-FQH/";3_;:9E9M M.2NR_-F+_YB]M;D4/;MUH^MRD[3B(:)U$T/+\D+=*7XWR<+;2^.=\=994769 M<%)#R0TE'S[0T5U*DIGQ&4_]I+EY<;@@^RS*C^KM'-?*;3HGUK%*9#6Z1=33 M+F@HOJ'XJML/6PKNIME5K0B\)FVN3D_<-WS2\,G9*HDS/GVO%=57.RW@])1" MPQ<-7YR+$FAH]VA-DT].<#:T=/(-N+/>JW<^6,<1NS39!)& MR32 -7R8!N[-K[?UIA&7>6]^90^.?TWPJA?#ER_XV)EWN$_K9M[1ANXY\ZXA MF@H13?XX2MW]/8D/TVB9?9G:"Y\'#254@Q)FQ ?MT[KB@S9TWT9)I]4V4J/D M;GH?4^^YY/J)S1ZO_]V)P'GPV6< XX1+/>S$SS,8"&WYPW_'9?_G*\-_YT;_ZE[WO#? M0H?=ZJS@N4:)[8F)JJ8T9KUNJ[,?KWLSZFM$^&F+S$-1G[ ]0");+;-'M@?_ MW$]I[6.8L/C6>4$U]BEY9)'X?"HN[6,8)5\6W@U;L?JCJE*Q:^NI4K&]>S5E M88Y!R^H+N*4W+FLY:/4IY\P>HJN+'UK:]N'R#Y?+/P>D.X#>$N M%''FCC.0"^VP7SN-X3\,$\;O'=C],QBYPD+"#!-7 P"V/1J,JD[UD0CKU@ MU;2K\3([;]' \O<<%DH@])9%6#_3>6 K-FX"'S?>MIN X)HZ_K]N@%5!=D:+ M"84X.WLC?6&+V1/F^VR8X/RW40B\D[RLFCY[1;Y1?GY,EWT?#NDZ+THL33#F M9S9:9NJ_^@E\Y+_]\'KV]:)A;XG_K[ET*#V^:OPM'$V=[A)^=?&)#[[S4'J: MD>/'C,^0&T =^6H:1?BU%P\=_Y_,B=9=2TN665TVFCKC-4GR#Y[/HBOXZ2&, M7DI/=C=V@!PB[3/#/&-"PA*,3O/#I"X8NVK0,O _P3;S6MN4W;&8D.5E: MM?')]AKKOWDIL^7%'ZE(3G3#Z@U-)<-/WCP6?76*'3:O7&;0W MA'"V(F^^GOX&(,7ZT-L WL M=3P$'P!>2?9;X?6R#)Q?8^]-X/D_ODJB*7NEO=X0@F),'1*"#3L<+%4SF?S9 MW5[--9>ME'"_W^[V3$N1T3,#;S)Q*>W:,=MMRS#*STR_/%+L/^;E MKS===,LT[$[7:"LHGQ]\L^G+++UEFD8'UF[M?OI9&3)?DWTM8C@86+9EVCVC MUVTO9Y&.W;=Z/?.8 ):#M&6W!UW;QOM_^P*UA.A93^KLF 6J#^!F3#(ON/8% MUZ7K>GB&Y/BWCN?>!%?.Q$L1+ ->R.X/N MP!K8ZT"'0=NLMMGO@3-&__D_S'T/'FPX#9)-=8%EM#N=3@;*RHEV ED9-=$& MB[[3WP*RO!EQZT2?(NH?X9)ZO64114!WZD3)H*JRDIN/'U[]9%RHGG0YP':W MG(U=K&HN9V,'K)K+V=@_J^9R-G;CJKF^D_3!+-D74[8= ?!T@/Y*\WP_Z#R_Y2Z_C5^_/J>/C$?V#!D.T]YTN6 ML!BF7:YE5]E855C+KA*US*6R]9C[X LY5+ ;(UU+MBAXV@EGNDG,]O$.K?Y%2BQ(P[ K+P(/@00*X1&5NM>LS! MH&O,<-:2N;8$:QYG50%KX^)>J]T+0_ZO@DO)58HJ9:?LWVHJ/++D)AN&8X4N[H(T66*3M7D]!?6Z*M>=?=]M;EF%W MV^W.KN8OVM*-,T%7W2K8")K2A+/7V==*[MPK))ND<*Y'M(1CKK#> Q/#MM,] M43)5.9OC3?U/(X7E,W;?!9-UNMVVJ9#X5@ =8W7[8Z�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�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�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�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end